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3D printing has been used extensively in medicine for education, surgical 
planning, and diagnostic assistance. It has also proven effective for load bearing 
structural implants, for addressing craniomaxillofacial reconstruction, and airway 
obstructions. To date, however, there are no clinical examples of additively 
manufactured soft devices. In this thesis, I will present an approach for the rapid 
prototyping of a patient-specific left atrial appendage (LAA) occluder via 3D printing 
and static molding of inflatable silicone/polyurethane balloons. The LAA is a structure 
known to be highly variable in geometry and the primary source of stroke for patients 
with atrial fibrillation. I describe the design workflow, fabrication, and deployment of 
these patient-specific occluders as a proof-of-concept, and show their efficacy using 3D 
printed anatomic models, in vitro flow loops, and an in vivo large animal model. My 
work demonstrates the first patient-specific LAA occluder. This occluder could offer a 
non-pharmacological alternative to current methods, particularly in cases where the 
morphology causes occlusion to be challenging. Additionally, the design process and 
manufacturing methods I present could be used in any application where patient-
specificity and soft materials are necessary.  
Proper delivery and deployment of LAA occluders requires exquisite knowledge 
of spatial orientation in delicate and complex anatomy. While real-time 3D ultrasound 
offers excellent navigation and interaction with soft-tissues, it requires a high level of 
expertise and implant materials with distinct ultrasound signatures for proper 
visualization and orientation. By incorporating sensory feedback into the skin of 
occluders, it could mitigate the need for complex imaging and expert skills. These skins 
 would provide direct feedback of their degree of inflation as well as contact pressure 
with surrounding tissues. In my thesis, I will show my work on soft, stretchable sensors 
that can be directly printed onto pre-fabricated devices via direct ink writing. This 
printing technique uses two inks—an ionically conductive hydrogel and an electrically 
insulating silicone—which are patterned and photopolymerized into capacitive sensors. 
When printed onto a pneumatically actuated haptic device, these sensors enabled the 
detection of a compressive force of ~2 N, and an internal pressurization of as low as ~ 
10 kPa.    
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Rapid Prototyping for Personalized Medicine  
 
Rapid prototyping was coined in the mid-80s as a group of technologies to quickly 
form 3D objects from layered material[1]. In the last ten years, this technology has 
received a lot of widespread attention due to the availability of low-cost, desk-top 
systems, such as the Fab@Home multi-material 3D printer pioneered by Cornell 
students. This technique transforms computer-aided-designs (CADs) into physical 
models by slicing the design into multiple layers and then depositing the desired 
material layer-by-layer, until the arbitrary geometry is realized. Depending on the 
chosen method of fabrication, a wide variety of materials are available, from soft, tissue-
like, hydrogels to rigid metals.  
Additive manufacturing has been used extensively in medicine for the 
fabrication of 3D models of organ systems for education, surgical planning, and 
diagnostic assistance (See Appendix A)[2-4]. These models are particularly useful in 
patients whose anatomy is abnormal due to birth defects, or a diseases state[3]. 
Additionally, if a surgeon needs to practice a procedure, or test out an off-the-shelf 
device on a patient’s anatomy then using a printed model of the patient is an ideal option. 
There have been major advancements in the use of virtual reality for surgical planning, 
but these systems can be expensive and we are naturally more adept at understanding a 
physical, tactile model.  
3D bioprinting is another application of additive manufacturing in medicine. The 
goal of bioprinting is to be able fabricate tissue constructs, vessels, or even whole organs 
for transplants, drug development, and basic research[5]. This field is heavily researched 
and will revolutionize personalized medicine.  
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The obvious application of 3D printing in medicine is for the fabrication of 
synthetic, patient-specific prosthesis and biomedical devices. The work in this area has 
been limited by material selection, cost, and the FDA approval process.  
 
1.3 Left atrial appendage  
 
The left atrial appendage (LAA) is a remnant of the embryonic left atrium that develops 
during the third week of gestation[6]. It is a small, irregularly shaped, and blind ended 
structure that protrudes from the left atrium of your heart (Fig. 1.1). Until recently, this 
appendage was considered to be of little importance to cardiac anatomy. It is now well 
accepted that more than 90% of thrombi in patients with non-rheumatic atrial fibrillation 
(AF) originate in the LAA[7]. The overall morphology and internal architecture are 
targeted as the main reasons for the increased incidence of clot formation in the LAA[6]. 
Removal or occlusion of the LAA for the prevention of a thromboembolic event is 
recommended for high risk patients with a contra-indication to anticoagulants[7].  
 
  
Figure 1.1| Explanted canine heart with left atrial appendage marked by arrow. 
This image shows the size and position of the LAA in relation to the whole heart. The 
image on the right also has the LAA marked by a yellow arrow. This is an adult, human 
specimen, the morphology of the LAA is highly irregular in morphology. (This image 
2 cm 2 cm 
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is from a conference talk by Dr. Reisman from the University of Washington, TCT 
2015.)  
 
1.3.1 Anatomy 
 
The LAA can have a variable number of lobes – which are used to classify the 
morphology type (Figure 1.2, top)[8]. Four major categories have been established by Di 
Biases et al: Cactus, Chicken Wing, Windsock, and Cauliflower. The cactus has one 
main central lobe with smaller lobes protruding from it. The Chicken Wing LAA has a 
central lobe that looks like it was bent half way down. The Windsock (Fig. 1.1, right) 
has a central lobe that curves back on itself in two places. The Cauliflower LAA is the 
most irregular of all – it has a variable number of lobes and lacks a central lobe. 
Additionally the overall size of the LAA is highly variable, its length can range from 16 
– 51 mm and its volume ranges from 0.7 – 19.2 mL[9]. The ostium is the opening 
between the left atrium and the LAA [10]. From the endocardial surface the ostium is 
well defined by ridge-like folds of the atrial wall (Fig 1.2, bottom left). Su et al. used 31 
heart specimens to measure the long and short diameters of the ostium; they show that 
the ostium is typically elliptical in shape and the long diameter ranges in size from 10-
24.1 mm long while the short diameter ranges from 5.2-19.5 mm wide[10]. Pectinate 
muscles can be found within the body of the LAA; large (at least 0.5mm in diameter) 
muscles are visible on computed tomography (CT) scans. Pectinate are large muscle 
bars that run from the top of the LAA to the bottom. The endocardial wall between the 
pectinate muscles can be extremely thin and delicate (Figure 1.2, bottom right). The 
LAA is surrounded by several key anatomical landmarks. On the endocardial surface, 
the LAA is in very close proximity (~10 mm) to the superior and inferior left pulmonary 
veins and the mitral valve (Fig. 1.2, bottom left). The circumflex artery runs just below 
the LAA along the epicardial surface (Fig. 1.2, bottom right)[10].  
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Figure 1.2| Left atrial appendage anatomy. The LAA morphology is categorized 
based on the number and placement of its lobes. (Top image was adapted from a 
conference talk by Dr. Reisman from the University of Washington, TCT 2015). Image 
on the left is an internal view of the ostium of the LAA with the long and short diameters 
marked by black arrows. The mitral valve (MV) can be seen to the right of the opening. 
Left superior and inferior (LS & LI) pulmonary veins are seen to the left of the ostium. 
The image on the right is a histology slice of the LAA. It shows the position of the 
circumflex artery (a) and vein (v). It also demonstrates how thin some regions of the 
LAA tissue wall can be between the pectinate muscles (enlarged on bottom right). (This 
image was adapted from Su et al, Interventional cardiology, 2008.) 
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1.3.2 Atrial Fibrillation, Stroke, and the LAA 
 
Atrial fibrillation (AF) is a very common cardiac arrhythmia effecting 2-4% of 
our elderly population[11]. Patients with AF have an increased risk of stroke that is 
independent of other risk factors, such as age and coronary artery disease[12]. This was 
particularly evident in a drug trial where participants with multiple cardiac diseases, (i.e. 
atrial fibrillation, hypertension, coronary heart disease) were given anticoagulants and 
an 80% reduction in stroke was observed. Since these drugs are only beneficial in the 
prevention of blood clot formation, and do not help with diseases such as hypertension 
and coronary heart diseases, it seems likely that AF was the main cause of stroke in the 
majority of these participants[12]. More recent studies have shown that approximately 
20-25% of all strokes each year are contributed to AF [7]. A study performed by Stoddard 
et al. has shown that patients with acute (<3 days) AF form clots in the left atrium and 
these clots are typically located inside of the LAA[11]. In a study performed by 
Blackshear et al., 23 separate studies were reviewed, they concluded that 91% left atrial 
thrombi originated from the LAA in patients with non-rheumatic AF[13]. 
 
1.3.3 Treatment Options 
 
Pharmaceutical  
 
Currently the gold standard of treatment for the prevention of stroke in patients 
with AF is oral anticoagulation therapy (i.e. Warfarin)[14], however, there are several 
challenges associated with the long-term use of Warfarin and other oral anticoagulants. 
Patients taking these drugs have to be vigilant with their food, alcohol, and drug intake 
as these could have negative interactions with the anticoagulants [7]. Additionally, 
Warfarin is associated with a narrow therapeutic window, therefore frequent blood 
draws for dose adjustments and monitoring needs to be performed[7]. If the dosage is 
too high, then the patient is at risk for internal hemorrhaging, however, if the dosage is 
too low then there is a risk of a thromboembolic event occurring. Currently, newer 
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anticoagulants are being developed that will hopefully avoid some of these challenges, 
however there is still a population of patients with AF who have contra-indications to 
the use of blood thinners, these patients need an alternative therapy[14,15].  
 
Surgical 
 
 Surgical closure or removal of the LAA is guideline recommended for patients 
who are having other open heart procedures such as mitral valve operations or Maze 
procedures[16]. There are currently two surgical approaches to achieve LAA obliteration, 
(1) amputation of the LAA at the base and stapling/suturing the epicardium closed, (2) 
exclusion of the LAA via suturing, stapling, or clipping (using a AtriClip™) at the base. 
Although these surgical techniques are relatively straightforward, they often result in 
incomplete closure[17,18], or remnant LAA present[19].  
 Katz et al. looked at 50 patients who underwent LAA obliteration via suture 
ligation and found that 36% had incomplete closure and therefore residual blood flow 
into the LAA[17]. This same value was reported again in a more recent study by Aryana 
et al., additionally, they showed there is a 24% increased risk of stroke in patients with 
incomplete LAA closure[18]. Closure success was also explored by Kanderian et al., they 
found that patients undergoing LAA amputation, 27% of patients had a remnant LAA 
present (cul de sac)[19]. Additionally, purse string sutures, used to ligate the LAA can 
leave a puckered suture line on the endocardial surface, these ridges are possible areas 
of thrombus formation[10].  
The AtriClip is a device made of rigid, titanium tubes held together by nitinol 
springs, the tubes have been covered with polyester fabric (Fig. S2.12). These tubes are 
opened and the LAA is slid in between them, the tubes are then clamped down at the 
base of the LAA. While initial studies have shown promising results using this device, 
there are still questions concerning damage to the LAA and surrounding structures, as 
this is a bulky, rigid device clamped to the delicate, thin tissue of the LAA in the 
epicardial space. Additionally, there may still be an issue if the clamp cannot get close 
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enough to the ostium, or if the endocardial surface is folded in such a way that would 
promote thrombus formation.  
 
Percutaneous interventions 
 
 Currently there are several devices available that can be implanted 
percutaneously (Fig. 1.3). This means that the device can be loaded into a small diameter 
catheter which is guided up through your femoral vein into your heart and delivered to 
the LAA by pushing it out of the end of the catheter. Some of these devices are available 
for clinical use in Europe and clinical trials in the United States[9]. There are only two 
devices FDA approved for clinical use in the USA, the Watchman and the LARIAT 
suture device. The majority of these devices are composed of a self-expanding nitinol 
frame with a polymeric covering, they are all circular in shape but claim conformability 
due to the architecture of the frame[9]. These devices come in a limited number of sizes.  
The LARIAT suture delivery system is unique to these other devices because it 
is placed on the epicardial surface. It is essentially the same as suture ligating the LAA, 
which was discussed in the previous surgical section. This device works by placing a 
catheter on the internal, distal end of the LAA and then placing a second catheter on the 
external surface, both catheters have a small magnet at their tips and can therefore locate 
and stick to each other. The suturing loop is then passed over the external catheter and 
the LAA, with the goal of placing it at the base of the LAA where it will be cinched 
down around the ostium. This is a very tricky method and has resulted in laceration of 
the LAA and emergency open heart surgery. The FDA has recently administered a 
warning concerning the clinical use of the LARIAT. 
The Prolipsis device is also unique because it does not use a nitinol frame. This 
device is made of a latex balloon with a polyurethane covering. The balloon is filled 
with contrast solution until it blocks the ostium of the LAA, next a type of surgical glue 
is delivered to the polyurethane patch to glue it to the internal wall of the appendage. 
This spherical device is currently undergoing animal trials[20].  
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 As mentioned above, the ostium of the LAA is typically elliptical in shape, while 
the majority of the devices discussed here are round in geometry. This mismatch in 
shape can cause crevices to form on either side of the device which leads to peri-device 
flow into the LAA[10]. To overcome this issue, interventionalists typically oversize the 
device they are implanting, with the goal of stretching the ostium into the shape of the 
device. This practice could lead to several problems: (1) hooks used to anchor the device 
could pierce deeply into the thin LAA tissue, possibly all the way through to the 
pericardial space, (2) anatomical structures that are in close proximity of the LAA can 
be damaged/blocked by the oversized device, (3) devices that are severely oversized can 
embolize from the LAA into the atrial space[10].  
 
 
Figure 1.3| Percutaneous occluders. Clockwise from top left: Watchman Flex, device 
produced by Boston Scientific, Nitinol frame with polyethylene terephthalate (PET) 
covering. Prolipsis, soft occluder by Sideris, composed of polyurethane patch around a 
latex balloon, spherical in shape. Lariat Suture Delivery by Sentre Heart. Amulet device 
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by St. Jude Medical, nitinol frame with Dacron polyester. Occlutech, nitinol frame with 
nanospun polyurethane covering. Coherex WaveCrest, nitinol frame with 
polytetrafluoroethylene (ePTFE) covering. (This image was adapted from multiples 
talks at TCT 2015; Sievert, H. et al., CardioVascular Center; Sideris, E.B.; Saw, J., 
University of British Columbia; Malik, I. Hammersmith Hospital; Whisenant, B., 
Intermountain Heart Institute.) 
  
1.4 Dissertation Scope and Organization  
 
The main body of my dissertation is broken up into three chapters. The first and 
second chapters describe the design, fabrication, and characterization of two generations 
of patient-specific, soft LAA occluders. The third chapter describes an approach for 3D 
printing soft, capacitive sensors onto the surface of a prefabricated object.  
The first generation LAA occluder, described in Chapter 2, is the first 
demonstration of a soft, cardiovascular implant based on 3D printing. I present a new 
class of cardiac occluder that can truly fully occlude any shape of the LAA by using two 
design schemes: (i) fabricating a soft material occluder that can inflate to conform the 
anatomy of the LAA, and (ii) using a patient-specific design derived from CT images. 
The occluder is an elastomeric device comprised of the following components: (i) a 
composite silicone material that dictates the mechanics of the balloon, (ii) a 
polycarbonate-urethane coating to provide hemocompatibility, (iii) a monolithically 
integrated valve to hold pressure upon inflation, (iv) a biocompatible filling liquid that 
cures to a solid to reduce long-term risk of leakage, (v) a monolithic plug that can be 
sutured to the LAA to prevent embolization of the occluder, (vi) a patient-specific 
design to ensure proper occlusion of the LAA without impinging on the surrounding 
tissue. I developed workflows for the design, fabrication, and deployment of this soft, 
patient-specific LAA occluder to prevent stroke in patients with atrial fibrillation.  This 
device demonstrates a novel approach for fabrication of personalized cardiovascular 
implants, which are durable and hemocompatible. Furthermore, the approach or similar 
incarnations can be applied more broadly to treat a variety of cardiovascular diseases, 
 25 
where the size and shape of conventional implants and/or complex patient anatomy 
exclude patients from treatment, or result in decreased device efficacy.  
 While the molding LAA occluder offers a robust workflow, scalable process, 
and large material variety it is a multi-step, labor intensive fabrication route with a 
minimum three day turn around and a minimum wall thickness of ~ 500 um. In order to 
decrease the time it takes to get these devices to patients in need, as well as decrease the 
wall thickness of the device, I chose to directly 3D print the second generation of 
occluders using Continuous Liquid Interface Production. This paper describes the 
design process and workflow for fabricating very robust 3D printing occluders in under 
12 hours. These occluders also show improved mechanics and reliability over the first 
generation. 
 The described occluders do not currently have any sensing capabilities. This 
added functionality would improve the positioning and deployment of this occluder. In 
the Chapter 4 I describe my work on 3D printing a sensing skin directly to the surface 
of a pre-fabricated (molded silicone) object. To enable this printing method I developed 
two viscoelastic inks – one that is a conductive acrylamide hydrogel, another that is an 
insulating silicone. By patterning these inks into alternating layers and then 
photopolymerizing them, I fabricated highly stretchable capacitive sensors.  
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CHAPTER 2     
 
PATIENT-SPECIFIC DESIGN OF SOFT OCCLUDER FOR THE LEFT 
ATRIAL APPENDAGE  
 
Sanlin S. Robinson, Seyedhamidreza Alaie, Hannah Sidoti, Jordyn Auge, Lohendran 
Baskaran, Kenneth Avilés-Fernández, Samantha D. Hollenberg, Robert F. Shepherd, 
James K. Min, Simon N. Dunham, and Bobak Mosadegh, Nat. Biomed. Eng., (2017) 
 
 
2.2 Introduction 
 
Atrial fibrillation (AF) is the most common cardiac arrhythmia, with 0.8 % to 1.9 % of 
the population affected[21]. Patients with AF are found to have a five-fold increase in the 
incidence of stroke[12], often attributed to the embolism of cardiac thrombi. Studies have 
shown that 90% of these thrombi originate in the LAA[13]; a tubular, blind-ended, and 
hooked structure protruding from the left atrium[6,8]. The LAA allows blood to become 
stagnant and clot when the atrium does not effectively contract (as is the case in patients 
with AF)[6,11]; stroke occurs when these clots embolize to the brain.  Currently, 
oral anti-coagulants (i.e. warfarin) are considered the gold standard of treatment for 
stroke prevention in patients with AF, however, the patients taking warfarin have a five-
fold increase in the risk of intracranial hemorrhage[7,14]. Non-pharmacological strategies 
that locally prevent the development of thrombi in the LAA include surgical excision 
or exclusion[17,19,22,23], and percutaneous occlusion of the LAA[7,9,14,20]. Recently, several 
companies have designed devices to occlude the LAA via transcatheter 
delivery[7,14,20,24]. Recently, the Watchman device from Boston Scientific was given 
FDA approval (but only for use in patients counter-indicated for oral anti-coagulants), 
giving much promise for transcatheter delivery of LAA occluders. Eventually, 
transcatheter embodiments of the device described here could have a huge impact, 
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however, a significant proportion of patients with AF still undergo open-heart surgery 
for other treatments, thus maintaining a need for LAA occluders that can be delivered 
during a surgical procedure. In fact, surgical excision or exclusion (stapling, suturing, 
or clipping) of the LAA is guideline-recommended concomitantly in AF patients 
undergoing mitral valve, coronary artery bypass, or aortic valve replacement 
surgery[16,18]. Despite evidence showing that surgical management of the LAA is 
effective, many surgeons do not perform this procedure due to significant risks 
associated with incomplete closure of the LAA (~60% of cases)[17,19]. Incomplete 
closure of the LAA has been reported to increase the risk of stroke from 2% to 24%[18]. 
Patients with incomplete closure often need to remain on anticoagulants, thus negating 
the goal of the procedure[18]. Also, suturing techniques can leave a puckered suture line 
on the endocardial surface of the atrium that could promote thrombus formation, while 
stapling methods can tear the paper-thin walls of the LAA[10].  
 
The poor outcomes of surgical techniques for excluding the LAA may be rooted in the 
fact that the size, morphology, and internal anatomy of the LAA varies dramatically 
among patients[8,9,25,26]. This variability may make it difficult for standard devices or 
techniques to seal the appendage[26]. The body of the LAA ranges between 0.77 and 
19.27 cm3 in volume and is trabeculated with small pectinate muscles[6,10,15]. 
Furthermore, even though cardiac radiologists categorize the shape of the LAA into 
general types – such as Chicken Wing, Cactus, and Cauliflower – the morphology and 
size is still highly variable within each of these categories [8,9,25,26]. The opening in the 
atrium that leads to the LAA is called the ostium. This eccentric, elliptical landmark 
varies dramatically in size with a short diameter ranging from 5-27 mm, and a long 
diameter of 10-40 mm[6,10]. Full closure of the LAA using current methods may become 
more challenging as the eccentricity of the ostium increases[26,27]. Without fully sealing 
the LAA, clot formation is promoted within the appendage (both on and off the device), 
ultimately increasing the chance of an embolic event[25]. 
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To address the issues of incomplete exclusion of the LAA, we have developed a patient-
specific, soft LAA occluder. This occluder is an inflatable balloon with a geometry 
matching the anatomical morphology of the patient’s own LAA, as ascertained by non-
invasive CT imaging (Fig. 2.1a). While a spherical balloon, composed of soft materials 
can conform to most shapes, patient-specificity is needed to minimize strain on (i) the 
elastomeric material of the balloon when inflated to fill complex, multi-lobular 
structures, and (ii) the LAA tissue and neighboring structures. Over-inflation of a 
spherical balloon to obtain full occlusion can impinge upon nearby anatomy[10] or result 
in unfavorable hemodynamic interfaces at the ostium of the LAA. From the CT images, 
we used segmentation software to produce 3D renderings of the blood volume within a 
patient’s LAA. This blood volume is then used as a template to make a thin-walled 
elastomeric occluder. Our lab has developed a composite elastomeric material 
comprising three commercially available polymers, two that are easily molded using 3D 
printed parts (defining the primary mechanics of the occluder), and a third that is known 
to be thromboresistant and biocompatible[28,29]. We chose compliant materials 
(extensibilities > 200%) yielding occluders that conform to the LAA morphology upon 
inflation. The occluder is monolithically integrated with a soft valve that enables the 
surgeon to fill the occluder without leakage once disengaged from the deployment 
apparatus (Fig. 2.1b, right). Following implantation, the occluder is filled with a 
biocompatible epoxy to stabilize it within the LAA. The full process of imaging a 
patient’s LAA, fabricating a patient-specific occluder, and surgically implanting the 
occluder into that same patient, has been performed on a single large animal model (Fig. 
2.7). Although further experiments are needed to assess the long-term performance of 
this novel device, this work serves as a proof-of-concept that 3D printing can be used to 
fabricate patient-specific and inflatable endovascular devices. 
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Figure 2.1| Patient-specific occluder design and deployment. (a) CT segmentation 
and image post-processing to isolate LAA (canine model). Left most image is cropped 
CT scan before segmentation to illustrate regions of interest. The next three images are 
after segmentation has been performed in Mimics®. In the segmented images the LAA 
is filled in with yellow, the left atrium (LA) is filled in with pink, and the left ventricle 
(LV) is filled in with blue. (b) We used the segmented LAA to design a patient-specific, 
soft occluder with a monolithically integrated valve. This occluder is hollow with a wall 
thickness of ~0.5 mm. We intended the valve for filling, anchoring, and retrieval of the 
occluder during the deployment process. A lumen is pierced through the valve to inject 
a filling solution. A suture made of nylon is threaded through the valve to retrieve this 
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occluder. (c) The occluder is delivered to the distal tip of the LAA using a catheter. The 
evacuated occluder is pushed out of the catheter during deployment. Finally, the 
occluder is filled through the lumen, until it fully occludes the LAA, and the catheter 
system is removed. The valve keeps the filling solution inside of the occluder to 
maintain the final volume. (b and c are SolidWorks® renderings of canine occluder 
deployment.)  
 
2.3 Design Considerations for a surgically deployed soft LAA occluder 
 
We chose to use a patient-specific design to enable stable anchoring and full occlusion 
of the LAA. Current occluder devices localize to the ostium of the LAA, and have 
standard circular geometries, resulting in potential leakage around the device in LAAs 
with an eccentric ostium[10,26]. Often these devices are oversized by 10-20% to achieve 
full occlusion; however, this puts unnecessary stress on the LAA tissue and surrounding 
anatomy[10,26]. By having a patient-specific occluder that inflates into the distal regions 
of the LAA, the anchoring surface area is maximized, thus minimizing the local stress 
required to achieve stable anchoring of the device in the LAA. Furthermore, filling the 
LAA volume prevents potential contractile forces from the LAA to induce hydraulic 
flow on the occluder, potentially causing its embolization. Also, the use of soft, 
elastomeric materials mitigates the risk of perforating the atrial wall and damage to other 
neighboring anatomical structures. The compliance of these elastomers also enables the 
occluder to conform to the anatomy of the LAA upon inflation, again, maximizing 
anchoring surface area. Since the elastomeric materials have relatively high levels of 
strain to failure (> 200%, Fig. S2.6), we undersized the occluder, facilitating easier 
insertion into the LAA. We also used smoothing operations, during the segmentation 
procedure, to simplify the geometry of the occluder, so its alignment to the morphology 
of the LAA does not need to be exact for proper occlusion. We designed a three-step 
fabrication process that leverages the advantages of 3D printing (i.e., simple fabrication 
of arbitrary geometries) and commercially available elastomers (i.e., with robust 
mechanics and biocompatibility). In the first step, we used a high-resolution 3D printer 
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to build a patient-specific template. In the second step, we used conventional molding 
techniques to fabricate a thin-walled occluder of a custom silicone blend of 
commercially available materials. In the third and final step, we dip-coated the molded 
silicone occluder in a polycarbonate urethane, which Bélanger et al. has shown to be 
safe for blood-contacting applications, such as heart valves and ventricle assist 
devices[29]. This three-step fabrication strategy allowed us to decouple the mechanics of 
the occluder from its hemocompatibility since our ability to fabricate robust occluders 
directly from the polycarbonate urethane was limited. We added a multifunctional valve 
to the occluder to enable inflation, delivery, recovery, and additional anchoring. We 
chose to use a biocompatible epoxy for the in vivo study for three reasons: (i) while it 
was a liquid its viscosity is low enough to flow through a 1 mm diameter lumen to inflate 
the occluder, (ii) its pot life of several hours was more than enough time to inflate/deflate 
the occluder several times throughout a procedure until the proper orientation was 
achieved, (iii) once hardened there is less risk of long-term damage of the occluder due 
to contractions of the LAA. 
 
2.4 CT Image Guided Patient-Specific Design 
 
To address the limitations of current LAA closure devices, we developed a patient-
specific design based on non-invasive CT imaging. Radiologists routinely perform 
cardiac CT imaging in preparation for LAA closure procedures; thus, this approach does 
not add unnecessary clinical imaging. Using image segmentation software (itk-SNAPã 
3.4; University of Pennsylvania, and Materialise Mimics® 18.0; Materialise), we 
isolated 3D surface profiles of the LAA blood volume from the surrounding 
cardiothoracic anatomy through a combination of automatic and manual segmentation 
methods (Fig. 2.1a). We then used computer aided design (CAD; Geomagic Wrap® 
2015; 3D Systems, and SolidWorks® 2016; Dassault Systèmes) to modify this 3D 
segmented LAA blood volume and design the occluder device (Fig. 2.1b, S2.1). We 
performed several post-processing procedures in Geomagic Wrap® to generate a 3D 
printable file: (i) removed non-moldable features of the LAA (i.e. pectinate muscles), 
 35 
(ii) reduced the size of the LAA by offsetting its surface profile inward by 1 mm 
(offsetting, unlike scaling, maintains the shape and proportion of the LAA morphology), 
(iii) smoothed the surface features of the LAA to meet the resolution of the 3D printer, 
(iv) shelled the surface profile to obtain the desired LAA occluder wall thickness of 0.5 
mm (which we determined experimentally to be the thinnest we could produce robustly 
using our current molding techniques), and (v) reduced the number of elements in the 
CAD in order to process the file in SolidWorks® (Fig. S2.1). Once we generated a 
shelled 3D rendering of the occluder, we assembled it with a custom-drawn 
multifunctional valve in SolidWorks® to enable coupling with a catheter (Fig. 2.1b). 
Next, we designed molds in SolidWorks® using this assembly as a template (Fig. 2.2a, 
S2.1). By producing occluders with geometries that match the morphology of the LAA, 
we may reduce the risk of leakage and dislodgement thereby potentially eliminating the 
exclusion of patients due to device incompatibility. 
 
2.5 Fabrication of Elastomeric Occluder 
 
We printed the above mold designs on a high-resolution 3D printer (Objet260 
Connex™, Stratasys) using both hard (Veroclear, Stratasys) and soft (Tango+, 
Stratasys) materials (Fig. 2.2b, S2.2). We designed the molds to facilitate a two-step 
fabrication of the silicone base of the occluder: first we formed the two halves of the 
occluder, and second, we bonded those halves together (Fig. 2.2b, S2.3). We designed 
the molds for the top-half of the occluder to include the integration of the 
multifunctional valve. We formed the two halves of the occluder by aligning the rigid 
(convex) molds, to their soft (concave) mates. We then filled the molds with a 
homogenous silicone blend of 69wt% Dragon Skin®20 (DS20; Smooth-On, Inc.), 
10.3wt% Silicone Thinner® (Smooth-On, Inc.), and 20.7wt% Sylgard®184 (Dow 
Corning; Fig. 2.2b). We added two drops of Smooth-On Ignite® Fluorescent Pink Color 
Pigment (Smooth-On, Inc.) to the translucent pre-polymer solution for better 
visualization throughout the molding process. We placed the molds containing the 
silicone blend in the oven at 100˚C for 35 minutes. Next, we carefully removed the 
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partially cured silicone part from the surface of the rigid, inner-wall molds and 
positioned them in the soft, outer-wall molds (Fig. S2.3). We designed these two soft, 
outer-wall molds such that the alignment structures on them fit together snugly. We 
bonded the two halves of the occluder together by carefully lining the edges of the 
silicone wall with DS20 pre-polymer, and then returning the molds to the oven at 100˚C 
for one hour. We used pure DS20 instead of the silicone blend for the seams because 
the pure DS20 had a higher viscosity and tended to stay in position after placement on 
the seam. We removed the fully formed silicone occluders from the molds and baked 
them at 100˚C overnight to ensure they were fully cured (Fig. 2.2c). We analyzed the 
uniformity and total thickness of the occluders by taking multiple cross-sections and 
imaging them on an optical microscope (Zeiss Stereoscope, Fig. 2.2d). When we 
excluded the seam region, we found a 25% variation in total wall thickness. We 
determined that the seams were up to twice as thick as surrounding areas (1 mm max).  
 
We then plasma treated the molded silicone occluder and soaked it in 12% by volume 
3-glycidoxypropyltrimethoxysilane (Silane, Sigma-Aldrich) in anhydrous ethanol 
(Sigma-Aldrich) for one hour. After cleaning and drying the occluder, we dipped it into 
a solution of ~10wt% polycarbonate urethane (PCU; ChronoFlex AR®, AdvanSource 
Biomaterials) in dimethylacetamide (Sigma-Aldrich; Fig. 2.2e). We placed the occluder 
into a 70˚C oven for 2 hours and then dipped it again into the PCU solution. Finally, we 
put the occluder in a 70˚C oven overnight to fully cure the PCU surface coating. We 
imaged multiple cross-sectional areas of the occluder using SEM (Nova NanoSEM, 
FEI) and found the maximum local variation of PCU layer thickness to be less than 
18%; the PCU layer was between 11-16 µm (Fig. 2.2f). For most LAA occluders, the 
surface of the device facing the left atrium will be covered by endothelial cells 
approximately 45 days after implantation, creating a wall of tissue between the left 
atrium and the LAA. Therefore, we tested the PCU surface material for compatibility 
with human endothelial cells and compared it to the silicone blend as well as a 
polystyrene control (full details in the Supplemental Information, SI). We found that 
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endothelial cells could attach to both the PCU and silicone blend materials, but that 
proliferation rates were lower than polystyrene, which we expected (Fig. S2.4).   
 
Using the methods described above, we fabricated patient-specific occluders of three 
typical morphologies of human LAAs: Cauliflower, Chicken Wing, and Cactus (Fig. 
2.3, S2.5)[8,25]. The Cauliflower (CF) LAA morphology is the most complex and 
irregular among these; it is typically multi-lobular, can have either a circular or elliptical 
ostium, and lacks a main lobe region[8,25]. The Chicken Wing (CW) LAA has a dominant 
central lobe with a large bend in its mid-region[8,25]. The Cactus (CC) LAA has a 
dominant lobe with smaller lobes extending from it in many directions[8,25].  
 
We tested the inflation performance of the occluders using a programmable syringe 
pump (Fig. S2.6, see SI). We attached the occluders to the syringe pump and a pressure 
sensor via their integrated valve, we then used LabVIEW™ (2013, National 
Instruments) to control the syringe pump to increase the volume at a rate of 2.5 mL/min 
while measuring the pressure until the occluder burst. We found that the occluders can 
go to at least ten times higher pressures and two times higher volumes than needed for 
LAA occlusion (Fig. 2.4a-b). Left atrial pressure is on average <2 kPa (<11 mmHg)[30] 
(Fig. 2.4a, left, red dashed line), while the occluders can achieve at least ~20 kPa of 
pressure before bursting.  The three LAA morphologies we used for this study are not 
of equal size, therefore to achieve full occlusion, we inflated the occluders to different 
volumes: CF occlusion volume is ~6 mL, CW occlusion volume is ~5 mL, and the CC 
occlusion volume is ~3 mL (Fig. 2.4a, right, red dashed lines; Fig. 2.4b, red box). We 
associate the variation in burst volumes to defects possibly created during the fabrication 
process (i.e. air bubbles either in the seams or the occluder walls), however, we found 
that the burst volumes of the PCU coated occluders are at least 127% above the required 
amounts for full LAA occlusion. 
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Figure 2.2 | Manufacturing patient-specific occluders. (a) SolidWorks® renderings 
of molds for a human’s Cauliflower (CF) occluder. (b) Photo of 3D printed molds of 
CF occluder with the molded silicone shown in pink. We printed convex molds in a 
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rigid material (VeroClear) and concave molds in a soft material (Tango+) on an 
Objet260 Connex™. Convex parts form the inner wall of the occluder, while concave 
parts form the outer wall. We monolithically integrated the valve in the molding process. 
(c) Photo of side view of molded CF occluder with seam traced with black dashed line. 
(d) Optical microscope image of a cross-sectional cut of molded silicone occluder, due 
to the molding process, the region around seam is slightly thicker. (e) Schematic 
illustrating layers of occluder. Silicone occluders are molded, treated with Silane, and 
then dip-coated with poly-carbonate urethane (PCU). (f) SEM image of the dip-coated 
PCU layer on the molded silicone layer. 
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Figure 2.3 | Highly variable LAA morphologies and fabricated patient-specific 
balloons. (a) Topside view of Geomagic Wrap® renderings of segmented blood volume 
of three LAA morphologies from left to the right: Cauliflower (CF), Chicken Wing 
(CW), and Cactus (CC). Photos of patient-specific LAA occluders designed and 
fabricated for these morphologies, (b) topside view and (c) underside view.  
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Figure 2.4 | Performance of inflated occluders. (a) (left) Burst pressures of occluders 
of varying morphologies, with typical left atrium (LA) pressure marked by blue dashed 
line. (right) Burst volumes of occluders with varying morphologies, with the target 
volume needed to occlude LAA marked by red dashed lines. (n ³ 5, error bars, mean ± 
s.d., data points displayed) (b) Cauliflower (CF), Chicken Wing (CW), and Cactus (CC) 
occluders inflated to various volumes. We placed red dashed lines above and below the 
target volume needed to occlude LAA, which we also boxed in red. 
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2.6 Performance of Valve 
 
We chose to monolithically integrate a valve into the occluder during the silicone 
molding process mentioned above since that would allow us to inflate the occluder to 
high pressures without delamination of the valve from its walls. We added wings to the 
internal side of the valve to protect the opposing wall of the occluder from getting 
pierced accidentally during deployment (Fig. 2.1b). We extended the top of the valve 
outside of the occluder to have a portion of it protruding from the distal tip of the LAA 
during the deployment procedure (Fig. 2.1b-c). This extension allows the surgeon to 
maintain physical contact with the occluder throughout the entire procedure. Also, this 
extension of the occluder acted as a secondary anchoring site after the surgeon sutured 
it directly to the LAA tissue (Fig. 2.6c, right).  
 
To test the performance of the valve, we integrated it into rigid spherical balloons (Fig. 
S2.7). In addition to the valve under test (which was the same size as the occluders), 
these balloons have a second larger valve used to attach them to a nozzle. These balloons 
were fabricated using the same methods as above for the LAA occluders, except instead 
of a PCU coating, we used a rigid epoxy (5Minute®Epoxy, Devcon) to dip-coat the 
silicone balloons. Before coating these balloons in epoxy, we inserted a nozzle through 
the larger valve. We then encased the balloon and part of the nozzle in epoxy, while 
leaving the test valve uncoated. Using a 0.45 mm needle, we pierced a hole into the 
valve under test, and then attached the fixed nozzle to the syringe pump (Fig. S2.6). We 
incrementally added water to these balloons at a rate of 0.25 mL/min while measuring 
the pressure (Fig. S2.7). We found the experimental setup failed between ~160-670 kPa, 
either the epoxy surrounding the balloon cracked, or there was a leak where we 
connected the tubing to the pressure sensor (we did not observe any leaks from the valve 
under test). Since the minimum pressure (i.e., 160 kPa) at which we observed failure in 
the setup was ~310% higher than the maximum pressure that the occluders can sustain 
before bursting (Fig. 2.4a, left), we don’t expect to see any leakage from the valves 
during their normal function.   
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2.7 In-vitro Occlusion of LAA 
 
We performed in vitro tests that mimic the environment and anatomy of the LAA using 
a custom-built flow system that provides a pulsatile fluid flow (Fig. 2.5a, left). Using 
the segmented LAA blood volume and CAD, we designed, and 3D printed molds to 
fabricate a silicone model of the human LAA CF morphology (Fig. S2.8, see SI for 
details). We then attached this model to our flow system that consists of an idealized 
left atrium connected to two centrifugal fluid pumps that mimic blood flow. A 
microcontroller (Arduino Uno™) acted as an alternating switch to regulate the flow 
produced by the two pumps. This alternation between the two pumps allows water to 
flow in and out of the LAA model in a pulsatile fashion.  
 
We implanted the CF LAA model with either a patient-specific CF LAA occluder (Fig. 
2.3a-c, left most images) or a spherical occluder (16 mm diameter; Fig. 2.5b). The size 
of the spherical occluder was chosen based on the average of multiple measurements 
taken using Geomagic Wrap's analysis tool across the LAA body just below where the 
valve would extend from the LAA. After implanting the occluder into the CF LAA, we 
added green dye (Food Coloring, Shurfine™) to the atrium of the set-up (Fig. 2.5b). We 
then waited to see if the green dye could flow past the ostium into the distal end of the 
silicone LAA. For each test, we increased the volume of the occluder by filling them 
with water dyed red (Food Coloring, Shurfine™) using a syringe. At smaller occluder 
volumes, the green dye quickly (< 1 min) leaked past the ostium and into the distal tip 
of the CF LAA.  However, as the volume inside the occluder neared the occlusion 
amount (~4mL for spherical and ~5.5mL for patient-specific), we waited longer times 
(~2 hours) to ensure no green food coloring leaked past the ostium.   
 
To determine the pressure inside occluder while it was in the silicone CF LAA model, 
we attached the previously describe syringe pump and pressure sensor and then added 
water to the occluder at a rate of 2.5 mL/min (Fig. 2.5A, right). The patient-specific 
occluder was designed to match the elliptical geometry of the CF LAA ostium. To 
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demonstrate this, we heated wax (Paraffin Wax, WaxWel) to 80 °C so that it was in its 
liquid state and then poured it into the silicone LAA up to the ostium, while the occluder 
was implanted and filled to the previously determined occlusion volume. We allowed 
this wax to solidify within the CF LAA (Fig. 2.5c, middle). We then peeled back the 
silicone CF LAA and removed the occluder with the wax still adhered to it (Fig. 2.5c, 
right). We found that there was approximately 210% larger volume of wax adhered to 
the spherical occluder versus the patient-specific occluder. Due to its size, the spherical 
occluder is seated further back from the ostium than the P-S occluder. If we had 
fabricated a larger diameter sphere, then it possibly could have protruded out to, or even 
past the ostium. However, a larger sphere could have also pushed on the walls of the 
LAA and probably the surrounding anatomy. 
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Figure 2.5 | Occlusion performance of patient-specific design. (a) Left, photo of in-
vitro flow loop to test LAA occlusion. Right, the pressure-volume behavior of occluder 
while implanted in silicone LAA. (n ³ 4, mean ± s.d.) (b) The schematic on the left 
represents the left atrium (LA) and CF LAA with either a patient-specific (P-S) or 
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spherical occluder in position. As we increased the volume inside the occluder, we 
started to block the green dye from the distal portion of the LAA, as seen in the photos 
on the right. We adjusted the contrast of these images in Photoshop® for better 
visualization of the green dye. (c) Left, photos of frontal view of the ostium of the 
silicone LAA with either P-S or spherical occluder implanted. The occluders have been 
filled with red dye. Middle, liquid wax was added to the ostium and allowed to solidify 
in place, ostium traced by black dotted line. Right, we removed the occluder with the 
attached wax from the silicone LAA (P-S is on the left of both top and bottom images).   
 
2.8 Delivery System 
 
We designed this soft occluder and, more specifically, the valve added at its distal tip 
for a surgical-based delivery and deployment. The delivery system consisted of 
polyimide lumen to transport the biocompatible epoxy (Epo-Tek® 301, Epoxy 
Technology) into the occluder (Fig. 2.1b, 2.6a). Using a rotational shear rheometer, we 
determined the cure time of this epoxy to be ~115 min at body temperature (37°C; 
Figure S9). This lumen was coupled to a sheath and a catheter, which were used to house 
the occluder and provide a hemostatic valve, respectively (Fig. 2.6a). Also, we threaded 
a nylon suture through the valve for retrieval and recovery in the chance of an embolized 
occluder (Fig. 2.1b, 2.6a). We attached the patient-specific occluder to the delivery 
system by inserting the lumen (1 mm outer diameter, OD; Medical Tubing, Vention) all 
the way through the valve. We did this by first puncturing the valve with a 0.45 mm 
needle, and then stretching the elastomeric material around a blunt, 1.8 mm OD metal 
tube. We then passed the lumen through this metal tube to the inside of the occluder, 
and we slid the metal tube out of the valve, in this way the elastomeric material of the 
valve sealed around the outer wall of the lumen. We attached a 3-way stopcock to this 
lumen and two syringes of different sizes (one 20 mL and the other 60 mL). We used 
the larger syringe to vacate air from the occluder, and the smaller syringe to fill the 
occluder with the biocompatible epoxy. We vacated and inserted the occluder into a 5 
mm inner diameter, transparent polyethylene terephthalate sheath (Medical Tubing, 
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Vention), which had two slits on its distal end. We then pulled this transparent sheath, 
containing the occluder, backward into the distal end of a 6 mm OD catheter (18 F, 
Check-Flo Performer Introducer, Cook Medical).  
 
 
Figure 2.6 | Delivery system and deployment method used in this study. (a) Photo 
of delivery system attached to occluder. Starting at outer-most layer and working inward 
toward the LAA: 18 Fr catheter cut to approximately four inches in length, transparent 
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semi-flexible polyethylene terephthalate sheath with two slits cut at its end, polyimide 
inner lumen extends into the occluder, nylon suture through valve of occluder. (b) 
Schematic of deployment method. Placement of purse-string sutures and insertion of 
the delivery system (left); deployment of soft, patient-specific occluder (right). (c) 
Orientation and inflation of occluder with epoxy (left). We tied the suture that is inside 
the valve to purse-string sutures. After approximately one hour, the epoxy starts to gel 
fixing it in place. After 24 hours, the epoxy is fully cured in place (right).  
 
2.9 Implantation of Soft Occluder in a Canine Model 
 
We demonstrated device functionality (delivery, deployment, anchoring stability, and 
occlusion) in the beating heart of a healthy, mongrel canine. The study was in 
accordance with the Guide for Care and Use of Laboratory Animals and was approved 
by the Institutional Animal Care and Use Committee of American Preclinical Services 
(Minneapolis, MN). The canine model was appropriate for this study due to the 
similarity to human cardiovascular systems, particularly the size and general 
morphology of the LAA.  
 
Two weeks prior to the surgical procedure the veterinary team obtained the canine’s 
cardiac CT scans using Siemens’ SOMATOM Definition (Fig. 2.1a, left; 2.7a, left). We 
used these scans and the methods described above to design and fabricate a soft, patient-
specific occluder (Fig. 2.7b). To reduce the risk of thrombotic events during the 
procedure, the veterinarian team placed the animal on antiplatelet (Aspirin, 81mg and 
Clopidogrel 75mg) one day prior to surgery. The day of the procedure, the veterinarians 
delivered general endotracheal anesthesia to the canine. The veterinary surgeons 
performed a thoracotomy and pericardial incision to access the LAA.  They placed a 
purse string suture in a pre-determined location on the distal end of the LAA (Fig. 2.6b, 
left). The surgeon then made an incision in the center of the sutures and guided the 
delivery system into the atrial space; pulling the purse-string sutures tight to prevent 
blood loss through the space surrounding the catheter (Fig. 2.6b, left). They retracted 
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the catheter to expose the transparent sheath, which contained the occluder. The slits in 
the sheath allowed the occluder to be released easily into the LAA (Fig. 2.6b, right). 
The surgeons then pulled the delivery system back, along with the occluder, until the 
top end of the valve of the occluder came through the distal tip of the LAA (Fig. 2.6c, 
left). Next, they cinched the purse string sutures around the elastomeric valve, 
preventing any bleeding through the LAA before they filled the occluder. They properly 
oriented the occluder under the guidance of fluoroscopy (Siemens Avantic) and 3D 
transesophageal echocardiography (TEE; Siemens Cypress II; Fig. 2.7c, left; S2.10-
2.11). Once oriented, we filled the occluder with the biocompatible epoxy until full 
occlusion of the LAA was achieved, as assessed through TEE and fluoroscopy. We then 
removed the lumen from the valve, and the surgeons used the sutures from the purse 
string and tied them to the nylon suture looped inside of the valve for additional 
anchoring. The veterinarians took cardiac CT scans immediately following the 
procedure (Fig. 2.7a-b, right). At that time, we viewed a bubble of air approximately 
170 µL in volume trapped inside of the occluder, possibly due to incomplete evacuation 
of air before infusion of the epoxy (Fig. 2.7b, right; Fig. S2.10). After 24 hours, the 
veterinarians performed a necropsy; the epoxy inside the occluder was fully cured, and 
the occluder was anchored in the correct orientation inside the LAA (Fig. 2.7c, right). 
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Figure 2.7 | Large animal in vivo study. (a) Coronal view of cardiac CT scan obtained 
two weeks before procedure, coronal view of cardiac CT scan immediately following 
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surgery (occluder outlined by yellow dotted line). (b) Soft, patient-specific occluder 
fabricated for this canine study, and sagittal view of the occluder (traced by yellow 
dotted line) within LAA in post-operative cardiac CT scan. In this image, the air bubble 
that became trapped within the occluder is visible. (c) Peri-procedure fluoroscopy image 
after inflation of occluder within LAA, and a photo of occluder anchored in place 24 
hours post-procedure necropsy.   
 
2.10 Conclusion  
 
We developed workflows for the design, fabrication, and deployment of a soft, patient-
specific left atrial appendage occluder to prevent stroke in patients with atrial 
fibrillation.  This device demonstrates a novel approach for fabrication of personalized 
cardiovascular implants, which are durable and hemocompatible. Furthermore, the 
approach or similar incarnations can be applied more broadly to treat a variety of 
cardiovascular diseases, where the size and shape of conventional implants and/or 
complex patient anatomy exclude patients from treatment, or result in decreased device 
efficacy.  
  
We achieved patient-specificity by using CT imaging to dictate the initial geometry of 
the occluder, and by fabricating the occluder as an inflatable balloon that can conform 
to the irregular shape of the LAA using an elastomeric composite of Dragon Skin®20, 
Sylgard®184, and ChronoFlex AR®. While medical balloons with custom geometries 
are commercially available, we demonstrate a process utilizing 3D printing for rapid 
fabrication of patient-specific LAA occluders that feature: i) a monolithic valve for one-
way filling of the occluder, ii) a method for anchoring to the LAA after deployment, 
and iii) development of composite elastomer layers and chemical treatments to bond 
those layers to ensure hemocompatibility and proper mechanics. Furthermore, we 
showed the advantage of patient-specificity over a less custom design (e.g., spherical 
balloons) through in vitro occlusion tests using our custom bench-top flow loop. We 
found that the personalized occluder prevents residual flow at much lower strains than 
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the spherical design. This improved performance will ensure safer operation of the 
occluder and decrease the risk of putting additional strain on the LAA and/or 
surrounding cardiac tissue. Additionally, the patient-specific design yielded smoother 
interfaces at the ostium of the atrium with smaller crevices than the spherical design; 
the smaller crevices suggest the patient-specific design will less likely be a nidus for 
thrombus formation. 
  
Although this work is a proof-of-concept, we demonstrated the feasibility of the 
workflow, functionality, and performance of our device by implanting it into a large 
animal model two weeks after cardiac CT scans were received. This timeline could be 
reduced to a few days and could easily be scaled up by printing multiple molds at a time. 
In this way, the cardiac surgeon could have several backup devices for a single 
procedure. We included a multifunctional valve in the design to enable the surgical 
deployment, filling, and anchoring of the occluder. We applied up to approximately 670 
kPa of pressure to these valves, demonstrating their ability to prevent any leakage. For 
the in vivo implantation, we used a biocompatible epoxy to fill the occluder. We 
obtained anchoring of the occluder through applying sufficient pressure to the walls of 
the LAA, conforming to the internal anatomy of the LAA, and suturing the valve to the 
distal end of the LAA. It should be noted that the valve material extending out of the 
LAA can be removed after suturing in order to reduce the profile of the occluder, since 
it is not the functional part of the valve, but simply used as a grasping region of the 
occluder for the surgeon. The patient-specificity and excellent orientation of the device 
is clearly demonstrated in the post-procedure cardiac CT scan and necropsy image.  
  
Other surgical techniques for exclusion (suture, stapling, etc.) have technical limitations 
that can result in incomplete closure, a remnant cul-de-sac, or even tears in the 
LAA[18,19,22]. We have performed a comparison of our patient-specific occluder to the 
AtriClipTM, as a demonstration (Fig. S2.12). Current percutaneous devices for LAA 
closure are composed of metallic wire mesh, are round, and do not take into 
consideration the elliptical shape of the LAA ostium. Currently, cardiologists tend to 
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implant oversized closure device in order to enhance anchoring and to reduce the 
crevices around the ostium of the LAA (due to placing a round device in an elliptical 
structure). However, this runs the risk of applying too much pressure to the thin LAA 
walls and surrounding anatomical features, such as the mitral valve, and the circumflex 
artery[10]. This method of oversizing could lead to perforation of the heart wall by the 
metal barbs used for anchoring or, in the rare case, embolism of a device that 
substantially oversized[14].  
  
Future studies should include a comparison of rigid and soft filling materials, 
hemodynamic flow analysis of the atrial-facing geometry of the occluder, and methods 
to decrease the overall form factor of the occluder. Saline solution or contrast dye are 
possible alternatives to using the biocompatible epoxy. They’re safe, and can also 
double as a contrast agent to aid in occluder orientation via fluoroscopy during 
deployment. However, since these liquids do not harden in place; it is important to 
assess of the mechanical deformability of the occluder within the LAA. Although the 
patient-specific geometry used in this study was an improvement over the spherical 
design, computational fluid dynamic studies could lead to optimized architectures. In 
its current form, the wall thickness of this occluder is too large, but by decreasing the 
form factor, we could fit it into a smaller catheter to deliver it percutaneously. Smaller 
occluders could be produced using alternate methods of fabrication, such as dip-coating 
PCU around a dissolvable template. Instead of the current valve design, flap valves 
would decrease the occluder's overall size. Tissue glue could be used to adhere the distal 
portion of the occluder to the LAA, instead of the sutures applied in this study. Future 
research should also include longer duration in vivo studies, which would assess 
endothelialization of the occluder at the ostium of the LAA, long-term stability of the 
device, clot formation when anti-coagulants are not administered, and any remodeling 
of the LAA. In addition, implants into additional animals should be performed to ensure 
the generalizability of this novel approach, beyond the in vitro experiments presented 
in this work. 
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Medical 3D printing has been used extensively for education, surgical planning, and 
diagnostic assistance[3,4,31-34]. This technology enables personalized, cardiovascular 
implants and prostheses to be designed and rapidly fabricated. Furthermore, 3D 
bioprinting of cardiovascular tissue, while still in its infancy, could potentially 
revolutionize the field of interventional cardiology[5,35-38]. Currently, with the exception 
of personalized, rigid mitral rings[39], no other rapidly prototyped endocardial devices 
exist[3]. This work demonstrates the first patient-specific LAA occluder. This occluder 
could offer a non-pharmacological alternative to current surgical excision or exclusion 
methods, particularly in cases where the morphology causes occlusion to be challenging 
using the available devices. Additionally, the design process and manufacturing 
methods presented here could be used in any application where patient-specificity and 
soft materials are necessary.  
 
2.11 Methods 
 
2.11.1 Statistical analyses  
Sample size, mean, and standard deviation are reported for all data sets. No statistical 
methods were used to pre-determine the sample-sizes for the characterization of the 
performance of the occluders. All statistical analyses were performed in Origin® 
(Academic Version, 2016) and Microsoft Excel (Excel for Mac, Version 15.32, 2017). 
 
2.11.2 Code availability 
 The LabVIEW™ and Arduino Uno™ codes that were used in this study can be made 
available upon request to the corresponding author.  
 
2.11.3 Data availability   
The authors declare that all data supporting the findings of this study are available within 
the paper and its Supplementary Information.  
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2.11.4 Image acquisition 
 
All photographs in the manuscript were taken with a Canon (EOS Rebel T3i), with the 
exception of Fig. 2.7c which was taken by the veterinary service performing the 
necropsy with an unknown digital camera.  
 
2.10.5 Image processing 
 
Except where explicitly stated (i.e. where we state that we changed the contrast), 
photographs were only cropped and positioned in figures using Adobe® Illustrator® 
(CS6, Version 16.0.3) and Adobe® Photoshop® (CS6, Version 12.0). SolidWorks® 
(Education Edition, 2016) renderings were performed using PhotoView 360® Add-In 
feature. Geomagic Wrap® (Version 2015) renderings were taken using the Snapshot 
feature. Pre-implantation CT images were obtained using Materialise Mimics® 
(Version 18). Post-implantation CT and fluoroscopy images were obtained using the 
Export Image feature of RadiAnt DICOM Viewer. Schematics were created using 
CorelDRAW® (Version 2017) or Adobe® Illustrator®. All arrows/dotted lines/text 
were added to images in Adobe® Photoshop® or CorelDRAW®. All plots were created 
in Origin® (Academic Version, 2016).  
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2.12 Supplemental Information 
 
 
 
Figure S2.1| Geomagic Wrap® renderings of post processing steps of segmented 
LAA blood volume. (a) Segmented LAA blood volume. (b) Non-moldable features 
removed. (c) Surface profile offset uniformly inward by 1 mm (d) Surface features 
smoothed to meet the resolution of the 3D printer. (e) Cross section of design to display 
0.5 mm inward shell. (f) CAD renderings of molds made in SolidWorks®.   
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2.12.1 CAD steps for occluder design 
 
We designed molds in SolidWorks® by first importing the STL file of the shelled 
occluder. We then chose a region on the superior, distal surface of the occluder to place 
a valve. We created a reference plane parallel to the chosen surface, and then extruded 
a cylindrical valve, 4 mm in diameter and 13 mm in length. Part of this extrusion (6 
mm) was on the outside of the occluder, and the remaining 7 mm was toward the inside 
of the occluder. We then added the wings of the valve by creating a small cutout at the 
inside end of this cylinder. This cut out was centered in the middle of the cylinder, it 
was 1 mm in width, and 2 mm in depth. Next, we created a reference plane which 
bisected the entire occluder. We chose a plane that would result in the least number of 
overhangs in the 3D printed mold. We extruded a box around the occluder, bisected it 
using this plane, and then removed the occluder using SolidWorks® combination-
subtraction feature. This resulted in four parts: (1) the internal bottom surface of the 
occluder, (2) the external bottom surface of the occluder, (3) the external top surface of 
the occluder, that also contained the external half of the valve (4) and the internal top 
surface of the occluder, that also contained the internal half of the valve, (Fig. S2.1F, 
respectively). Once these four parts were created, we added alignment markers so that 
they would all fit together properly. 
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Figure S2.2| Photos of 3D printed molds for three LAA occluder morphologies (a) 
canine model used in the animal study. (The opaque, rigid mold on the far left was 
printed using VeroWhite. The opaque, soft molds in the middle were printed using 
Tango+. The transparent, rigid mold on the far right was printed using VeroClear.) (b) 
human chicken-wing, and (c) human cactus.  
 
 59 
2.12.2 3D printing mold 
 
Once the molds were designed in SolidWorks®, we printed them on our Objet260 
Connex™ (Stratasys) high-resolution printer. We printed the internal molds using 
VeroClear, and the external molds using Tango+ (shore hardness of 85). To get a very 
smooth molding surface, we used the glossy setting and oriented the molding surface 
facing upward in the printer. Do to the irregular shapes of the LAAs, there were some 
regions where overhangs occurred, the printer is programed to lay down support 
material in these regions.  
 
 
Figure S2.3| Silicone occluder molding process. (a) Molding two halves of the 
occluder, silicone is blue. (b) Bonding those two halves together using the same molds 
from the first step ensuring proper alignment. SolidWorks® renderings. 
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2.12.3 Fabricating occluders  
 
After the parts were printed on our high-resolution printer (Objet260 Connex™, 
Stratasys), we cleaned them by scraping and power-washing away any support material 
from the print process. We then submerged them in regular tap water, and placed this 
into a 100°C overnight. Post-baking these printed parts is necessary to avoid mold 
inhibition. After baking overnight, we dried the molds, cleaned them again with an 
isopropanol (IPA, Sigma-Aldrich) soaked cotton swab, and then spray them with a thin 
coat of release agent (Polytetrafluoroethylene Film Release Agent, LPS). We let the 
release agent dry completely and then wiped away any excess residue with a cotton 
swab.  Next, we mixed and degassed a pre-polymer solution of 69wt% Dragon Skin®20 
(DS20; Smooth-On, Inc.), 10.3wt% Silicone Thinner® (Smooth-On, Inc.), 20.7wt% 
Sylgard®184 (Dow Corning; Fig. 2.2b), and two drops of Smooth-On Ignite® 
Fluorescent Pink Color Pigment (Smooth-On, Inc.). We put a small amount of this into 
a syringe with a long, blunt tip (1.5 mm inner diameter). This syringe was used to inject 
pre-polymer material into the cavity that would mold the valves. We filled each mold 
with pre-polymer, and placed all the molds under vacuum to remove air bubbles. We 
then slowly pushed together the matching molds, placed glass plates (3”x2”) on either 
side of the mold and secured them with large binder clamps. We placed these molds 
into the oven at 100˚C for 35 minutes. We bonded the two halves of the occluder as 
described above. We post-baked these occluders overnight at 100˚C. We rinsed the 
balloons in IPA and then air-plasma treated (PE-25, Plasma Etch) them on all both sides. 
We then quickly transferred them into a sealed container of 12% by volume 3-
glycidoxypropyltrimethoxysilane in anhydrous ethanol (Silane, Sigma-Aldrich) for one 
hour. Since the occluders were full of air – and therefore buoyant - we placed the sealed 
container onto a benchtop shaker, the constant movement ensured all sides of the 
occluders were exposed to the Silane solution. We used forceps to remove the occluder 
by the distal end of the valve, we then sprayed them with IPA to remove excess ethanol. 
We sprayed them with nitrogen gas to remove the isopropanol and put them on a clean 
piece of foil into the 60°C oven for approximately five minutes to dry off any remaining 
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solvent. Next, we dip-coated the occluder in PCU. We diluted the received PCU 1:1 
with dimethylacetamide (Sigma-Aldrich). We cured the PCU coating in the oven at 
70˚C for 2 hours and then dipped the occluder a second time into the PCU solution. We 
did a final cure overnight at 70˚C.  
 
2.12.4 Occluder wall thickness  
 
The uniformity, of the total thickness of balloons was studied by slicing two occluders 
in different regions and imaging of the cross-sectional areas using an optical 
microscope. After studying 7 cross sectional areas, the variation of total thickness, 
excluding the seam area, was found to be less than 25%. The seams were found to be 
up to 100% thicker than the other areas.  
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Figure S2.4| Endothelialization experiments. (a) Optical microscopy imaging of 
endothelialization of polystyrene (PS), polycarbonate urethane (PCU) and silicone 
blend after 1, 3, and five days. We adjusted the contrast of images using ImageJ for 
better visualization. (b) Cell count of endothelial cells on the materials used to fabricated 
occluder, plus the control of PS. (n = 5, mean ± s.d.) 
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2.12.5 Endothelialization of polymer materials 
 
We cultured EA.hy926 human endothelial cells in a Dulbecco's Modified Eagle's 
Medium (DMEM), which was the base of the media containing essential amino acids 
and vitamins, along with 10% Fetal Bovine Serum, and 1% Penicillin and Streptomycin. 
We cultured the cells and waited until we observed confluence. After we observed 
confluence of the cells, we passaged the cells into a different flask to a 1:5 dilution cells 
to media ratio to keep them alive to run biocompatibility tests. Endothelial cells are 
adhering cells; therefore, the following protocol was used to suspend the cells into the 
media. Once we observed confluence, we removed the media via aspiration, and we 
performed a wash with Phosphate Buffered Saline (PBS), then aspirated the PBS and 
incubated the flask is for 5 minutes in a solution of 0.25% Trypsin-EDTA to suspend 
the cells. Once cells are suspended, we added media to stop Trypsin toxicity to the cells, 
and re-suspend the cells. After that, we extracted the volume necessary for a 1:5 
dilutions and incubated the cells until we observed confluence. We fabricated samples 
by spin-coating the silicone blend onto the surface of a 1x4 inch cover slip. We set aside 
half of the glass cover slips and UV sterilized them for cell culture, the other half we 
treated with 12% by volume 3-glycidoxypropyltrimethoxysilane in ethanol to apply a 
PCU coating, using the same procedure as the occluders mentioned above. Once the 
PCU was fully cured, we sterilized the samples using UV.  We used 600,000 cells in 15 
mL of media to culture these two samples, along with a control sample of polystyrene 
(PS). After culture, we took digital images of 5 different points on the samples using a 
camera attached to the microscope at different times; one day, three days, and five days. 
The day after culture, we washed the plate with PBS and added new media, to remove 
any debris. We analyzed the images and averaged the cell counts to see the trend of 
confluence in the samples and control (Fig. S2.4). To facilitate better visualization of 
the cells in ImageJ the images of the cells were first Inverted, and then the Contrast was 
adjusted. Cells were manually counted using the Cell Counter tool in ImageJ. Counts 
were recorded in Excel. Data was analyzed in Origin®.  
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Figure S2.5| 3D printed LAAs containing patient-specific occluders of various 
morphologies. From left to right, Cauliflower, Chicken Wing, and Cactus 
morphologies are demonstrated. We printed these LAAs on a high-resolution 3D printer 
(VeroBlue RGD 840, Objet24; Stratasys.) and cleaned away the support material 
manually. We then implanted the patient-specific occluders and inflated them within the 
LAA.    
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Figure S2.6| Pressure-volume set-up and tensile tests. (a) Photo of pressure-volume 
test set-up. (b) The uniaxial tensile behavior of Sylgard® 184, Dragon Skin®20, and the 
silicone blend of the two used in this study. (n ³ 8, mean ± s.d.) 
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2.12.6 Pressure-Volume Tests 
 
All Pressure-Volume data in this manuscript was collected using custom LabVIEW™ 
code. The code controlled the input volume through a programmable syringe pump (NE-
1000, New Era Pump Systems Inc.) and accepted the output pressure data from a 
pressure transducer. For the burst pressure and volume tests of the occluders we used a 
0-15 PSI pressure transducer (PX26-015DV, Omega). If occluders were found to have 
holes/leaks at the beginning of the test, then they were discarded. We tested at least five 
distinct samples of each PCU coated and uncoated occluders.  
 
2.12.7 Uniaxial tensile test 
 
We performed tensile tests according to ASTM D412 on a Zwick Roell z010 instrument.  
All tests were conducted at room temperatures using a 10 kN load cell and a strain rate 
of 35 mm/min-1. We fabricated samples by mixing and degassing each of the pre-
polymer materials, and then pouring them into dumbbell molds. We then degassed these 
molds a second time and cured the material at room temperature. We tested at least 8 
distinct samples of each silicone variety. The data were averaged across common X 
range and plotted with standard deviation. We chose to skip every 25 points to make 
data more visible 
 
 67 
 
Figure S2.7| Valve performance. (a) SolidWorks® renderings of 20mm diameter 
spherical balloon with a wall thickness of 2mm. (b) Cross-section of CAD of the 
spherical balloon showing dimensions. The valve under test is the same dimensions as 
the fabricated occluders. (c) A needle was integrated into the balloon through the larger 
valve, and the entire sample was then coated with a layer of epoxy ~1mm thick, 
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excluding the valve under test. (d) Maximum pressure values from valve test. (n = 8, 
box determined by 25th and 75th percentile, black bar is mean, whiskers are s.d., data 
points displayed in red.) 
 
2.12.8 Valve Tests 
 
 The pressure-volume data of the valves was collected in the manner as the burst 
volume/pressure of the occluders. However, the valves could go to much higher 
pressures, so we used a pressure transducer that could go up to 100 PSI (TDH30-CG-
0100-03-D004, Transducers direct). We used 8 distinct samples when testing the valve 
performance. Samples that were tested inconsistently due to user error were discarded 
(i.e. testing the same sample twice, not adequately filling balloon before start of test).  
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Figure S2.8| 3D printed parts for benchtop flow test.  (a) 3D printed (VeroClear, 
Objet260 Connex™) three-part mold and silicone (Sylgard® bottom, Ecoflex® 0030 
(Smooth-On, Inc.) upper) molded part of human LAA cauliflower morphology. (b) 3D 
printed bench top flow system zoomed in and angled to show ostium. Looking from the 
atrium into LAA. 
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2.12.9 Occlusion test  
 
Each volume aliquot was tested three times for each occluder geometry. The same 
occluder (either patient-specific or spherical) was used throughout the test. Between 
each test the entire flow set up was cleaned and clear tap water was added to the system. 
Occluder filled with pre-determined volume was implanted into silicone LAA model. 
Flow was initiated by powering pumps (ZKWP03A, FORT-RIC). Dye was added to 
atrium. We waited for the dye to diffuse to the distal end of LAA. We photographed the 
occluder after the dye diffused to distal tip, or after approximately two hours (whichever 
came first). If the dye did not diffuse to distal end of LAA after 2 hours we called that 
occlusion.  
 
2.12.10 Inflation of occluder within silicone LAA  
 
For the pressure-volume data of the occluder implanted in the silicone LAA, we used 
LabVIEW™ to control an automated syringe pump to inflate the occluder and record 
data from a 0-15 PSI transducer (TDH30-CG-0015-03-D004, Transducers direct). The 
same occluder (either patient-specific or spherical) was used multiple times for this test. 
Data was imported into Excel® and converted into SI units. Data was then imported 
into Origin® where it was analyzed. Only tests that were run on the same day were used, 
four tests of patient-specific and six tests of spherical occluders. Data was averaged 
across X range and plotted with standard deviation. We chose to skip every 50 points to 
make data more visible.  
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Table S2.1. Descriptive data for a variety of occluder morphologies (mean ± s.d.). 
 Cauliflower Chicken Wing Cactus 
Occlusion Volume (mL) 6 5 3  
Burst Pressure (kPa) 34.2 ± 4.6 27.4 ± 0.7 30.0 ± 2.9 
Burst Volume (mL) 31.8 ± 15.1  39.4 ± 11.0 29.7 ± 19.5  
Molded Thickness (µm) 500, 25% variation 
PCU Thickness (µm) 11-16, 18% variation 
Valve Pressure (kPa) 387.3 ± 185.92 
 
 
 
Figure S2.9| Complex viscosity over time of biocompatible epoxy (EPO-Tek® 301) 
at 37C.  
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2.12.12 Isothermal curing of EPO-Tek® 301  
 
We performed isothermal (37°C) oscillatory rheology on the biocompatible epoxy using 
a cone (25 mm, 2°) and plate geometry at a frequency of 1.7 Hz, and a magnitude of 
oscillation of 1°. Data was collected using <0.5 mL of material on a rotational shear 
rheometer (Discovery Hybrid HR-3 Rheometer; TA Instruments). Only a single sample 
was tested. We plotted the complex viscosity as a function of time for this epoxy. The 
viscosity diverges toward infinity at the gelation point of the epoxy, this is the 
approximate time at which the surgeons can expect that the epoxy is no longer flowing 
inside of the occluder. We found this time to be approximately 115 minutes.  
 
 
 
Figure S2.10| Post-procedure 3D Echo. SolidWorks® rendering of segmented air 
bubble from post-implantation CT scan of canine heart (bottom).  
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Figure S2.11| In-vivo, surgical deployment of patient-specific LAA occluder in the 
beating heart of a canine model. Surgeon maintains contact with the occluder during 
deployment: (1) nylon suture is looped through the external portion of the occluder’s 
valve (this nylon string is kept out of the way by keeping it within a tube), and (2) 
forceps can also be used to clamp to the protruding tip of this valve as shown in this 
image.  
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Figure S2.12| Comparison of patient-specific occluder and AtriClip™ LAA 
Exclusion System in an explanted canine heart. (a) Patient-specific, elastomeric 
occluder positioned within the LAA of canine heart, top and side views show soft 
protruding tip of occluder valve. The external portion of this valve can be removed with 
scissors after deployment of occluder. Right most image is of the ostium region of the 
occluder as seen from within the left atrium. (b) AtriClip™ LAA Exclusion System, 
with white AtriClip™ clamped around the LAA of explanted canine heart. Clip applier 
is still attached to the AtriClip™ to display the overall size of the delivery system. The 
clip size used here was 35 mm, the smallest size available. Right most image shows 
what the ostium of the LAA looks like after the AtriClip™ has been clamped down on 
the LAA.  
 
2.12.13 Obtaining patient-specific scan of explanted canine heart 
 
We thawed frozen canine hearts (Sierra for Medical Science; Whittier, CA) in lukewarm 
water for four hours. We then used a scalpel to remove unneeded tissues, including the 
majority of the left ventricle, taking care not to cut any portion of the left atrium or left 
atrial appendage. We used a cyanoacrylate gel (Loctite 454) to block the pulmonary 
veins, and finally a zip-tie to ensure a complete seal. We then suspended the heart upside 
down and poured silicone pre-polymer (Ecoflex 00-30; Smooth-On, Inc.) down the open 
left ventricle into the left atrium, taking care to fill the left atrial appendage. We let this 
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cure at room temperature for four hours. At this point the cured silicone mold was 
removed and the canine heart was stored in the refrigerator at 4°C. We spray painted 
the silicone using a matte silver color (Acryli-quik™; Krylon Industrial™) to allow for 
better visibility of the part during 3D scanning. Finally, we used a 3D scanner (Matter 
and Form; Toronto, CA) to obtain an STL model of the silicone mold.  
 
2.12.14 Human CT Scans used in study  
 
The IRB had determined that as only de-identified CT scans are being used for purposes 
of writing this manuscripts and other publications, this did not meet the definition of 
research with human subjects in accordance with the human research regulations at 45 
CFR 46 and no separate IRB approval is needed
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CHAPTER 3  
 
STEREOLITHOGRAPHY FOR PERSONALIZED LEFT ATRIAL 
APPENDAGE OCCLUDER  
 
Sanlin S. Robinson, Cameron Aubin, T. J. Wallin, Saleh Gharaie, Patricia A. Xu, Simon 
Dunham, Bobak Mosadegh, Robert F. Shepherd, in submission, (2017) 
 
3.1 Introduction 
 
         Mass-produced medical implants typically come in several standard geometries 
and sizes which often fail to address the various patient morphologies encountered, 
particularly when a patient’s anatomy is in a diseased state. With the advancements in 
high resolution imaging modalities, segmentation software, and rapid prototyping[1-4], 
the development of patient-specific implants has become more accessible to the medical 
community. To date, personalized implants have been fabricated for a variety of medical 
applications, such as airway disorders[5], mitral valve insufficiencies[6,7], 
craniomaxillofacial defects[8,9], and orthopedic replacements[10-12]. Due to 
manufacturing and chemistry limitations, most of these custom implants require 
fabrication from high elastic modulus (E > 1 GPa) materials that are mechanically 
dissimilar to the soft, elastomeric tissues of the human body (E  < 1 MPa) [13]. Such rigid 
devices fail to conform to surrounding tissues, concentrate stress, and can perforate 
tissues[14]. Here we present a fast (~3 cm hr-1 draw-rate), low-cost ($0.25 mL-1 of 
material), and scalable workflow for fabricating patient-specific medical implants via 
direct 3D printing of elastomeric polyurethane (EPU). To demonstrate this workflow, 
we have fabricated patient-specific left atrial appendage (LAA) occluders (Fig. 3.1a) for 
those at high risk of clot formation due to atrial fibrillation (AF).  
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         Patients with AF have nearly a five times greater risk of stroke due to cardiac 
emboli[15], where 91% of these emboli originate in the LAA, possibly due to the low 
flow velocities of blood within this convoluted structure[16]. Blood-thinners are currently 
the first line of therapy to prevent stroke in high-risk patients, however, these drugs are 
effective in a narrow therapeutic window, require frequent and ongoing monitoring, 
increase the risk of internal bleeding, and can negatively interact with the individual’s 
physiology or other drugs[17]. Therefore, occlusion of the LAA is recommended as an 
alternative for stroke prophylaxis[18-20]. Conventional surgical resection of the 
appendage not only hinders the contractile function of the remaining left atrial tissue[21] 
but also often results in incomplete closure (~36% of cases) which increases the risk of 
stroke[22,23]. The associated risks leads many practitioners to avoid recommending 
surgical interventions for occlusion. As an alternative, some mechanical LAA occlusion 
devices use a self-expanding metal alloy (nitinol) cage, available only in a set number 
of sizes, that deploy into a round dome to cap the ostium of the appendage[18-20]. 
Implantation of such rigid devices requires physically anchoring it using hooks that 
concentrate mechanical stress and can cause tears in the LAA and neighboring tissues, 
which presents significant challenges to safe delivery, proper deployment, and long-
term health. Additionally, due to the high variability of LAA morphology – standardized 
occluder geometries often fail to completely block the ostium from residual blood flow. 
[14,24,25]. 
 
         Recently our labs have shown the efficacy of patient-specific, soft, hollow LAA 
occluders [Robinson et al., Nat. Biomed. Eng. 2017] implanted in a canine model to 
address the issues of incomplete occlusion, perforation of LAA tissue, and device 
anchoring. Construction with elastomers is key to this advancement—the highly 
compliant endovascular devices are selectively inflated to fully conform to the complex 
LAA morphology at low volumes, which minimizes stress and damage to the 
surrounding tissues.  Though fabricated via rapid prototyping (i.e., replica molding, 
lamination, and dip-coating), the workflow for constructing personalized occluders 
remains laborious and time-consuming; we required at least three days to fabricate the 
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patient-specific designs. Additionally, this strategy of manufacturing is incompatible 
with potentially un-moldable morphologies and requires a lamination step that 
introduces a seam that creates non-uniform wall thicknesses and compromises the 
mechanical integrity of the device. Herein, we demonstrate a rapid approach where we 
perform segmentation of the LAA from cardiac computed tomography (CT) scans, 
create a computer aided design (CAD), and 3D print the custom geometry to realize a 
monolithic, thin-walled elastomeric LAA occluder (Fig. 3.1). This process requires only 
~12 hours. 
 
         Though various 3D printing technologies (e.g., Direct Ink Writing, Fused 
Deposition Modeling, Selective Laser Sintering)[7,26-28] have been used in medicine, we 
chose to use stereolithography (SLA) as it is especially promising in the fabrication of 
implanted devices. Based on layer-by-layer solidification of a liquid resin in response 
to photopatterned light (Fig. S3.1) SLA enables direct fabrication of complex, hollow 
elastomeric architectures with feature sizes on the order of 100 µm[2,29,30]. Additionally, 
by projecting multiple images onto the same build stage, we can rapidly (tprint ~1.5 hr) 
manufacture in a single print (i) multiple design variations for the same patient (i.e. 
iterate design complexity; Fig. S3.2a), (ii) multiple occluders for different patients (Fig. 
S3.2b, S3.3), and (iii) multiple copies of one design for one patient (i.e. scale up 
manufacturing; Fig. 3.1c). 
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Figure 3.1| Direct 3D printing of patient-specific (PS) left atrial appendage (LAA) 
occluder. (a) Schematic of heart with right atrium (RA), right ventricle (RV), left atrium 
(LA), and left ventricle (LV) labeled. The ostium is the opening between the LA and 
LAA. PS occluder is implanted into the LAA and conforms to the surrounding tissue. 
(b) CT Segmentation of left heart blood volume, isolation of LAA, CAD design of PS 
hollow occluder with 300 µm wall thickness, 3 mm diameter valve, and drainage holes 
for venting during printing. (c) 3D printing of PS occluder. Freshly printed part is in 
delicate green state. Final printed PS occluder after cleaning and full cure. PS occluder 
implanted into 3D printed LAA.  
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3.2 Design of patient-specific occluders for 3D printing 
 
         We used non-invasive, human cardiac CT scans to guide the design of patient-
specific (PS) occluders, a method thoroughly described previously by Robinson et al. 
[Robinson et al., Nat. Biomed. Eng. 2017] (Fig. 3.1b). Briefly, we used open-source 
software (ITK-Snap, University of Pennsylvania) to perform semi-automatic image 
segmentation on the left heart blood volume from human CT scans. We used additional 
image processing software (Geomagic Wrap, 3D Systems) to isolate the LAA, then 
smoothed the surface and shelled the object for 3D printing a hollow structure with a 
wall thickness of 300 µm. To prepare the design for direct printing, we used 
SOLIDWORKS (Dassault Systems) to (i) add a valve to the ostial surface of the 
occluder, and (ii) insert drainage holes to reduce vacuum forces that occur during SLA 
printing of  hollow structures (Fig. 3.1b).  
  
3.3 Fabrication of patient-specific occluders 
 
         We used a high-resolution SLA printer (M1, Carbon, Inc.) and a commercial 
elastomeric polyurethane (EPU, Carbon) resin to directly print custom LAA occluder 
designs (Fig. 3.1c). Using our 141 mm x 79 mm build stage, 10 - 15 occluders can be 
printed at once, greatly increasing the fabrication speed over previous methods. After 
photopolymerization, the “green bodies” are fragile and covered in liquid resin (Fig. 
3.1c). We used isopropyl alcohol to gently clean resin off both the external and internal 
surfaces. The drainage holes that allowed for venting of the hollow prints aid in the 
removal of encapsulated, unreacted resin inside the occluders.  Applying a thin layer of 
fresh resin over these holes, followed by exposure under a UV light source (ECE 5000, 
Dymax Inc.) sealed the green body. A post-processing thermal treatment (120°C for 8 
hr) fully cured the EPU material to obtain the full elastomeric properties (Fig. 3.1c, 
3.2a). Lastly, we injected silicone pre-polymer (Ecoflex 00-30, Smooth-On) into the 
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cavity of the valve where it interlocks and cures with printed crossbars to create a self-
sealing valve (Fig. 3.2a). By iterating this design-fabrication process with patient-
specific (PS; i.e. Chicken Wing) and spherical morphologies, we empirically 
determined the minimum wall thickness (t = 318.6 ± 49 µm) compatible with our 
printing process (Fig. 3.2b). Replica molding pathways for similar elastomeric 
occlusion devices could only achieve thickness with large dimensional variance, t = 500 
± 125 µm. The final printed PS occluder, when compressed, fits into an 18 Fr Catheter 
(d = 6 mm) for surgical intervention (Fig. 3.2c). 
 
         Our material choice also imparts important mechanical performance to the 
printed devices.  Compared to other available SLA materials, EPU is an excellent 
candidate owing to its large elastic strain regime (γelastic > 300%; Fig. 3.2a) and high tear 
strength (Gtear = 23 ± 3 kN m-1). Combined, these properties lead to a robust, highly 
deformable device even when dimensions are miniaturized. Despite having a 40% 
thinner wall, these devices operate safely at pressures and volumes (ΔP > 60 kPa, ΔV > 
50 mL; Fig. 3.2c, S3.4) that exceed the corresponding failure regimes of their replica 
molded silicone counterparts (ΔPburst ~ 30 kPa, ΔVburst  ~ 40 mL) [Robinson et al., Nat. 
Biomed. Eng. 2017]. 
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Figure 3.2| Features of 3D printed, patient-specific occluders. (a) Schematic of 
printed valve before and after filling with silicone. The printed crossbars (black) lock 
the added silicone (blue) in position so no covalent bonding is necessary (left). The 
uniaxial tensile behavior of elastomeric polyurethane (EPU; n = 11, mean ± s.d.). (b) 
Cross-section of occluder with cross-section of valve inset. Right, optical microscope 
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image of cross section of occluder wall next to reticle for measuring wall thickness, t ~ 
318.6 ± 49 µm (n = 9, mean ± s.d. from 3 occluders). (c) Comparison of PS and spherical 
occluders pressure-volume behavior (left, n = 7, mean ± s.d.). Right top, image of PS 
occluder evacuated and inflated to very large volumes using air (ΔP > 50 kPa) Right 
bottom, potential delivery method, PS occluder within an 18 Fr catheter (outlined by 
dotted line).  
 
3.4 Stable anchoring and resistance to embolism 
 
         Another concern with implanted occluders is the possibility of device 
embolization into the left atrium.  To probe the long-term viability of our printed 
geometries, we conducted in vitro pull-out tests at different device inflation volumes, 
Vinflation = (Vinjected/Vrest)*100  (Fig. 3.3a). We 3D printed a custom attachment for the 
bottom grip of our tensile tester (Zwick & Roell, z010) that replicates the Chicken Wing 
LAA anatomy (Fig. 3.3b, S3.5). We implanted either a patient-specific (PS) or spherical 
occluder (rrest = 8.75 mm) into the LAA. After implantation, we pulled on the ostial 
surface of the occluder until it popped out of the simulated appendage (Fig. 3.3b, S3.5). 
We report the maximum force during separation as a function of inflation volume (Fig. 
3.3a, Table 3.1). These forces dramatically exceed those required to dislodge the 
Watchman and Amulet occlusion devices (Fpull-out ~ 3.5 N), which make use of nitinol 
hooks to pierce the tissue for anchoring. For the PS morphology, we estimated a 
minimum occlusion volume of Vinflation ~ 200% (see supplemental information for 
details) which corresponds to a pull-out force of approximately Fpull-out ~ 14.9±1.47 N. 
Increasing the volume of both the PS and spherical occluders logically increases the 
pull-out forces, but likely impinges upon the adjacent anatomy. In particular, the 
spherical samples with large inflation volumes (Vinflation >150%) visibly deformed the 
simulated LAA, which is consistent with our observations that non-PS geometries have 
the potential to strain and damage LAA and neighboring tissues while attempting to 
fully occlude the ostium. 
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         Whereas the pull-out measurements were made on a static appendage, the in vivo 
atrial environment is dynamic. The oscillating pressures within the heart, coupled with 
the expansion and contraction of the atria may contribute to device embolism at forces 
below the above measured thresholds. Here, we simulated the LAA anatomy using a 
silicone phantom attached to an idealized left atrium flow loop (Fig. 3.3c, S3.6).  After 
implanting our printed device, we controlled the operation of two pumps at pulsatile 
flow (f ~ 1 Hz) and pressure regimes (ΔP ~ 15 kPA) that approximated the systolic and 
diastolic behavior of the left heart (ΔP ~ 16 kPA; Fig. 3.3c). Table 1 notes any embolism 
event or damage to the LAA phantom during subsequent continuous operation for 48 
hours. We found that both PS and spherical occluders embolized when they were 
underinflated, Vinflation ~ 50% (Fig. S3.7). We also observed that over-inflation (Vinflation 
> 200%) of spherical occluders tore the silicone LAA within the first 24 hours (Fig. 
S3.8).  
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Figure 3.3| Pull-out and embolism performance of patient-specific (PS) vs spherical 
occluders. (a) PS and spherical occluders filled with Ecoflex 00-30 up to Vinflation ~ 
200%. (b) 3D printed pull-out test jig attached to Zwick tensile tester (left). Force 
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needed to pull occluder out of LAA when inflated by increasing amounts (n = 5, mean 
± s.d.). (c) Schematic of embolism test set-up. PS or spherical occluder was implanted 
into the silicone LAA for 48 hours to see if occluder would embolize (left). 
Physiological pressure drops ΔP ~ 15 kPa and frequencies (f ~ 1 Hz) were maintained 
throughout the 48 hours.   
 
Table 3.1| Embolism and pull-out test results for occluders of various inflation 
volumes. (n = 5, mean ± s.d.) 
Vinflation 50% 100% 125% 150% 200% 
Embolism Test Results 
PS Embolized Stable Stable Stable Stable 
Spherical Embolized Stable Stable Stable Tore LAA 
Pull-out Test Results [N] 
PS  2.0±0.22 2.4±0.27 3.8±0.14 5.0±0.19 14.9±1.47 
Spherical  1.9±0.22 3.0±0.17 4.4±0.30 8.0±0.64 16.8±1.78 
 
3.5 Hemodynamic flow analysis of atrial-facing geometry   
 
         Current mechanical closure devices available are round in shape, while the 
ostium of most LAAs is elliptical. This mismatch in geometry causes large crevices to 
form on either side of implanted occluders, this can lead to residual flow of blood into 
the LAA and to clots forming on or around the device. To ensure stable anchoring and 
to mitigate this residual flow, these round devices are typically oversized by 8-20%[31]. 
While this practice helps eliminate blood flowing into the appendage, it does not 
diminish – and may worsen – the severity of the crevices between the occluder and the 
atrial wall. The ability of our printed LAA to change volume in a “balloon-like” manner 
is a key differentiator compared to existing LAA occluders, and allows them to conform 
to the LAA anatomy. The atrial-facing geometry of our occluders was designed from 
the CT scans to exactly match the existing anatomy.  
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 We used computational flow dynamics (CFD) to analyze the atrial-facing 
geometry of patient-specific and spherical occluders (Fig. 3.4). We used SolidWorks™ 
to assemble either a PS or spherical occluder into the appendage of a Chicken Wing 
LAA morphology. After creating a solid body and mesh we then performed the flow 
analysis. We overlaid the heatmap results from the wall shear stress of both the PS and 
spherical geometries over their left heart models (Fig. 3.4b-c). We observed that the 
regions along the edges of the spherical occluder had very low wall shear stress regimes 
(Fig. 3.4c). Previous studies have correlated low wall shear stress regimes with clot 
formation. These areas of low wall shear stress were not as pronounced in the PS design 
(Fig. 3.4b). We believe this is because the PS design is better matching the internal atrial 
wall.  
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Figure 3.4| Computational hemodynamics of the atrium facing wall of a PS or 
spherical occluder. (a) Fluid domains discretization with 441,162 tetrahedron 
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elements. Right superior pulmonary vein (RSPV), right inferior pulmonary vein (RIPV), 
left superior pulmonary vein (LSPV), and left inferior pulmonary vein (LIPV) are the 
inflow regions. The ostium is not visible from this surface view, but its position on the 
interior surface has been outlined using a yellow dotted line. The Chicken Wing 
morphology LAA has also been highlighted. The outflow region is the left ventricle, it 
has been cropped out. (b) Model of left heart with patient-specific (PS) occluder within 
the LAA, it has 472,741 tetrahedron elements. The wall shear stress heatmap of the 
atrial wall of the occluder has been overlaid on the model. (c) Model of left heart with 
spherical occluder within the LAA, it has 408,667 tetrahedron elements. The wall shear 
stress heatmap of the atrial wall of the occluder has been overlaid on the model. Note 
the areas of dark blue on the outer edges. These are located where crevices have formed 
between the occluder and the atrial wall. 
   
3.6 Conclusion 
 
         We developed a strategy for quickly and accurately producing patient-specific 
left atrial appendage occluders for patients with atrial fibrillation who have a high risk 
of stroke. These occluders are directly printed using elastomeric polyurethane and 
function as inflatable balloons that can conform to the patients’ anatomy at inflation 
volumes Vinflation ~ 200%. While previous manufacturing strategies are too laborious for 
practical implementation [Robinson et al., Nat. Biomed. Eng. 2017], we can fabricate 
10-15 patient-specific devices in under 12 hours for under $3.00 per device by using 
stereolithographic 3D printing. Our hollow devices simultaneously possess thin walls (t 
~ 318.6 ± 49 µm) that enable surgical implantation and robust mechanical properties 
(DPburst > 60 kPa, DVburst > 50 mL). Our work demonstrates a facile method for quick 
and scalable production of personalized cardiovascular implants. Additionally, our 
methods could be more broadly applied to other areas of medicine, where soft materials 
and patient-specificity are needed.  
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 Using CT segmentation and methods described in our previous publication 
[Robinson et al., Nat. Biomed. Eng. 2017] we achieved patient-specific designs that met 
the resolution and capabilities of our 3D printer. We added a silicone valve to enable 
rapid inflation and deflation of these thin walled elastomeric balloons. We demonstrate 
the stable anchoring of these occluders within a simulated appendage by measuring the 
pull-out force, and testing the long-term implantation of the occluder. We found that the 
pull-out force needed to dislodge a fully inflated PS occluder was Fpull-out ~ 14.9±1.47 
N, and that only underinflated occluders (Vinflation ~ 50%) were not stable over long 
periods of time in our bench-top flow loop. We used CFD to investigate the wall shear 
stress of the atrial surface of a spherical vs a patient-specific occluder. We found that 
the spherical occluder tended to have regions of very low wall shear stress around the 
edges of the device where crevices formed between the device and the atrial wall. These 
low shear regions could be areas where clots start to form around the spherical device, 
this was not observed in the PS device. We did not investigate hemocompatibility of 
our base EPU material. Previous work, however, demonstrates a straightforward process 
to sterilize and impart hemocompatibility onto complex polymeric 3D surfaces without 
drastically affecting final shape or wall thickness [Robinson et al., Nat. Biomed. Eng. 
2017]. 
 
 In its current form this occluder can fit into a d = 6mm catheter (18 Fr), this is 
too large for a percutaneous delivery and therefore would need to be delivered 
surgically. Future work should address decreasing its form factor in order to fit it into a 
d = 4 mm catheter (12 Fr). A potential route to achieve this goal, while maintaining the 
current limitation of minimum t ~ 300 µm wall thickness, would be to introduce 
pleating. These pleats would enable us to more easily compress the device into small 
catheters. Additionally, by re-designing the valve into a flap we could also decrease the 
evacuated size. We noticed that the regions of high curvature tended to collect extra 
resin after the device was printed, by smoothing these occluders in the design process 
we could mitigate the resin collection in these regions and have more uniform wall 
thicknesses. Future work should also include hemocompatibility, and long term 
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durability testing in order to assess how well these occluders would perform in vivo 
where biological interactions can be unpredictable.  
 
 As the resolution, capabilities, and library of materials increases for 3D printers, 
they are becoming increasingly useful to the medical community. Currently, medical 
printing is used mostly for education and surgical planning[28,32-34], there are a few 
examples of using it to fabricate patient-specific devices. We are not aware of any 
previous work that uses 3D printing to directly fabricate a soft, patient-specific 
endocardial device. Previous work by our groups demonstrated a design and 
manufacturing process for soft, patient-specific LAA occluders, however these were 
manually fabricated and took at least 3 days to create an occluder for a single patient. 
Here we demonstrated improvement over our previous process by fabricating thin 
walled personalized endocardial implants in under 12 hours using fast, scalable SLA 
printing.  
 
3.7 Experimental 
3.7.1 Uniaxial tensile tests 
We performed tensile tests according to ISO 37 on a Zwick Roell z010 instrument.  All 
tests were conducted at room temperatures using a 10 kN load cell and a strain rate of 
200 mm min-1. The data were averaged across common strain range and plotted with 
standard deviation (n = 11). We chose to skip every 25 points to make data more visible.  
 
3.7.2 Thickness variation  
We took three specimens from three different occluders, for a total of nine samples. We 
used a razor blade to slice portions of the printed occluder in a variety of areas. We then 
used an optical microscope (Zeiss) to image these samples against a reticle of known 
dimensions (Fig. 3.2b, right). This reticle was fabricated by etching lines with set 
dimensions into acrylic using a laser cutter (Epilog Zing 50W, Epilog Laser). The 
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images were processed using ImageJ by measuring each specimen in three positions. 
We calculated the mean and standard deviation using Microsoft Excel (Excel for Mac, 
Version 15.32, 2017). 
  
3.7.3 Pressure – volume tests  
All Pressure-Volume data in this manuscript was collected using custom LabVIEW™ 
code (Code can be made available upon request, National Instruments). The code 
controlled the input volume through a programmable syringe pump (NE-1000, New Era 
Pump Systems Inc.) and recorded the output pressure data from a pressure transducer 
(0-100 PSI, TDH30-CG-0100-03-D004, Transducers direct). These tests were 
performed on fourteen occluders (7 patient-specific, 7 spherical geometries). Each 
sample was inflated and deflated five times. To avoid non-linear effects in the stress-
strain behavior of the base polymer, we only used the fifth recording to determine the 
mean and standard deviation between the samples (Fig. 3.2c).  
  
3.7.4 Pull-Out Tests 
To characterize the pull-out force required to remove our devices from the LAA, we 
designed and 3D-printed a custom testing set-up which could be attached to a Zwick 
Roell z010 tensile tester (Fig. 3.3b). We used elastomeric polyurethane (M1 Carbon, 
EPU) to fabricate an anatomically correct LAA and secure this to one end of a rigid 
adapter (Objet30 Scholar Stratasys, Veroblue) which connects to the load cell of the 
tensile tester.  We then inflated six PS occluders (with a Chicken Wing morphology that 
corresponded to the LAA in the testing rig) and six spherical occluders to six different 
volumes (Vinflation ~ 50% to 200%). We backfilled the occluders with an RTV-silicone 
pre-polymer (Ecoflex 00-30, Smooth-on) blended with 10 wt% silicone thinner 
(Smooth-on) which allowed for easier injection. After the silicone fully cured, we 
threaded a loop of Kevlar through the ostial surface of the occluder (Fig. S3.5). We 
properly positioned and oriented the occluder within the simulated LAA and secured 
the Kevlar string to the moving head of tensile tester. Next, we pulled the occluder back 
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out of the LAA at a rate of 25 mm min-1 while recording the tensile force (n = 5). We 
report the maximum tensile force applied to the occluder during this pull-out test. 
 
3.7.5 Embolism Tests 
A custom benchtop flow-loop determined if the PS or spherical occluders would 
embolize during the first 48 hours of implantation (Fig. 3.3c, S3.6). This setup was 
modified from one described in our previous publication [Robinson et al., Nat. Biomed. 
Eng. 2017]. Briefly, we attached a sealed, 3D printed idealized left atrium to two pumps 
(ZKWP03A, FORTRIC), a patient-specific silicone LAA, and a pressure transducer (0-
15 PSI, TDH30-CG-0015-03-D004, Transducers direct; Fig. S3.6). A relay switch 
alternatively operates these pumps at physiological rates (f ~ 1 Hz). An external 
reservoir feeds and collects water from these pumps. By placing this reservoir at a height 
~15 inches below the flow loop, we produce a pressure of ΔP ~ 15 kPa inside of the 
chamber. We then implanted our occluder into the simulated LAA and took pressure 
readings at 0, 24, and 48 hours to ensure we maintained the desired physiological 
pressure range. 
3.7.6 Statistical analyses 
Sample size, mean, and standard deviation are reported for all data sets. No statistical 
methods were used to pre-determine the sample-sizes for the characterization of the 
performance of the occluders. All statistical analyses were performed in Origin® 
(Academic Version, 2016) and Microsoft Excel (Excel for Mac, Version 15.32, 2017). 
 
3.7.7 Code availability 
The LabVIEW™ and Arduino Uno™ codes that were used in this study can be made 
available upon request to the corresponding author.  
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3.7.8 Data availability 
The authors declare that all data supporting the findings of this study are available within 
the paper and its Supplementary Information.  
 
3.7.9 Image acquisition 
All photographs in the manuscript were taken with a Canon (EOS Rebel T3i). 
 
3.7.10 Image processing  
Except where explicitly stated (i.e. where we state that we changed the contrast), 
photographs were only cropped and positioned in figures using Adobe® Illustrator® 
(CS6, Version 16.0.3), Adobe® Photoshop® (CS6, Version 12.0), and PowerPoint 
(Microsoft Office). SolidWorks® (Education Edition, 2016) renderings were performed 
using PhotoView 360® Add-In feature. Geomagic Wrap® (Version 2015) renderings 
were taken using the Snapshot feature. Schematics were created using Adobe® 
Illustrator®. All arrows, dotted lines, and text were added to images in Adobe® 
Photoshop® or PowerPoint. All plots were created in Origin® (Academic Version, 
2016). 
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3.8 Supplementary Information 
 
 
 
Figure S3.1| Schematic of stereolithography printing process. Printed parts are cured 
layer by layer after exposure to UV light. Printed parts are pulled out of the liquid resin.  
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Figure S3.2| Schematic of LAA occluders on print head. (a) Complex features, or 
smooth parts for the same patient can be printed on a single print. (b) LAA occluders 
for 3+ different patients can be fabricated on a single print.  
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Figure S3.3| Multiple patient-specific occluders can be printed simultaneously. (a) 
CAD renderings of CT segmented LAA for three typically encountered LAA 
morphologies, Chicken Wing (CW), Cactus, and Cauliflower. (b) 3D printed 
morphologies inthe green state. (c) Fully cured LAA occluders for three patient 
morphologies.  
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Figure S3.4| Pressure – volume test set-up. Occluders were attached through their 
plug onto the tip of a 30 gauge needle. They were then inflated with air up to 60 mL 
(size of syringe) while the volume input and pressure output was being recorded in 
labview VI. Each sample (n = 6) was tested five times and the 5th recording was used to 
determine the mean pressure and standard deviation of the samples. 
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Figure S3.5| Pull-out test. Kevlar thread (yellow) was looped through the ostial surface 
of the occluders and then attached to the upper crosshead of the tensile tester. The 3D 
printed LAA test-jig was attached to the bottom grip of the tensile tester. Occluders 
(which were prefilled with Ecoflex 00-30) were inserted into the LAA and then pulled 
out. (1-4) Images of the various stages of the test. 
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Figure S3.6| Embolism test set-up. Pumping water at physiological frequencies f = 
1Hz. Measuring pressure within the idealized left atrium. Reservoir sits ~ 15” below left 
atrium chamber. 
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Figure S3.7| PS and spherical occluders embolized when they were underinflated, 
Vinflation ~ 50%. In this image, the PS occluder is visible within the idealized left atrium 
of the flow set up. This demonstrates embolism of a device.  
 
 
Figure S3.8| Image of hole that was torn in the silicone phantom LAA by the Vinflation 
~ 200% spherical occluder during the first 24 hours of testing.  
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4.2 Introduction 
 
Human development, intelligence, and survival are intimately linked to tactile (i.e. touch 
and pressure) and kinesthetic (i.e. position and movement) feedback we receive from 
millions of mechanoreceptors embedded in our skin.[1,2] These highly specialized 
receptors are capable of transmitting signals through ionically conducting nerve fibers 
at rates of up to 70 m s-1.[2] When these sensors are deformed mechanically—perhaps 
by compression of the skin or contraction of a muscle—an action potential is transmitted 
along afferent pathways then processed in the central nervous system.[2] An appropriate 
response to the input stimulus is then returned along efferent neuronal pathways.[2] This 
sensory-motor coupling allows us to effortlessly perceive and interact with our 
environment, enabling the performance of complex tasks such as avoiding furniture in 
the dark or playing the piano. Due to skin’s significant role in learning, tool 
manipulation, and gross motor coordination, the development of a synthetic analogue 
will enable new methods of feedback control in robotics, medical monitoring, and 
human-machine interfaces. Wearable[3] and implantable electronics[4] have been 
developed to integrate with human tissue, which is soft, three-dimensional, and 
mechanically dynamic.  
 
Along with the development of stretchable electronics, the field of soft robotics has been 
gaining traction as a result of their ability to (i) interact gently with biological 
organisms,[5,6] (ii) easily conform to their surroundings,[7-9] and (iii) achieve complex 
motions using simple modes of actuation.[10-13] These robots are typically composed 
of hyperelastic materials (e.g. silicones) with large ultimate strains, ϒult ~400-700%, 
that have embedded networks of pneumatic channels (PneuNets). These pneumatic 
actuators are powered through inflation, similar to a balloon. A critical limitation of soft 
robots is the availability of compliant and extensible sensors[14] that can (i) reliably 
detect external stimuli and internal actuation, (ii) be easily integrated with current 
manufacturing processes, (iii) function at the high strains encountered throughout 
actuation, and (iv) tolerate many actuation cycles without delamination.  
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To address these sensing deficiencies many groups have developed flexible and 
stretchable sensors that use changes in resistance,[15-17] capacitance,[18,19] light,[20] 
or resonant frequency[21,22] to detect deformation. Specifically, for soft robots that 
undergo large deformations, shape sensing is a critical need for feedback control 
(communicating with a central computer to ensure a machine task is being completed 
accurately). Therefore, we focus on sensing techniques using stretchable capacitors due 
to their high precision and sensitivity over large ranges of strain and pressure.[23,24]  
 
Here we present a highly extensible sensing skin that we integrated with soft, pneumatic 
actuators via a 3D printing technique called direct ink writing (DIW; Fig. 4.1). This skin 
enables soft machines to sense external stimuli as well as their own shape, thus creating 
a device that has both tactile and kinesthetic sense. Central to our approach is the 
development of two viscoelastic fluids—one that is ionically conductive (hydrogel 
elastomer precursor) and another that is electrically insulating (silicone elastomer 
precursor). We directly patterned these inks by extruding them in alternating layers 
through micronozzles of two different diameters, dhydr=330 µm and dsil=250 µm, on our 
custom dual-head 3D printer. The two inks are yield-stress fluids that flow through our 
print heads at high shear rates and retain their shape after exiting the nozzles due to their 
viscoelastic properties. After extrusion, we used in-situ photopolymerization of the inks 
to chemically crosslink them into conductive hydrogels and insulating silicones with 
large ultimate strains, 𝛾"#$%$&	> 350% and 𝛾()*+%$&  > 300% (Fig. 4.2, S4.2). When patterned 
into alternating conductive and dielectric layers, these composite skins behave as 
stretchable capacitors, capable of transducing low mechanical stresses and large strains 
into electrical signals. We printed these stretchable capacitors onto soft, Pneumatically-
powered Haptic Displays (PHD; Fig. 4.1, S4.1) to provide sensory feedback control. 
We characterized the ability of the PHD to (i) detect touch (tactile sense), (ii) detect its 
own actuation (kinesthetic sense), and (iii) integrate these two senses for sensory-motor 
coupling. 
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Figure 4.1| Overall device schematic. (a) Image of pneumatic haptic display with wells 
where electrical contacts will be formed, underlying pneumatic chambers, tubing and 
electrical wiring. (b) Image of printing stretchable sensors onto pneumatic haptic 
display. (c) Fully printed sensor on surface of pneumatic haptic display; (inset) 
Schematic of printed layers of conductive polyacrylamide (green) and insulating 
silicone (blue).  
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4.3 Ink Preparation 
 
We chose to use DIW because it offers material flexibility, rapid design iteration, low 
cost,[25-27] and facile integration with previously established soft robot fabrication 
methods (i.e. replica molding[8] and rotational casting[9]). In addition, the rheological 
properties of many polymeric inks can be modified to enable this printing technique.[28-
30] Specifically, both the shear thinning and yield stress properties of these complex 
fluids can be adjusted so the inks flow smoothly out of micronozzles and retain their 
shape after being printed. The shear thinning exponent (n), storage (G¢) and loss (G¢¢) 
moduli are primarily controlled by the high molecular weight polymer constituents.[30] 
To tailor the rheology of the silicone elastomer precursor, we prepared blends of high 
and low molecular weight silicones (60 wt% Nuvasil® Loctite 5039, 40 wt% Wacker 
® Semicosil 912) together into a homogenous melt (details in supplemental information, 
SI). In this system, the high molecular weight polymer serves to adjust the yield stress, 
while the low molecular weight one polymerizes into a resilient matrix. We chose 
silicones because they have very high electrical resistivity (on the order of 1013 Ω×m), 
low leakage currents,[31] high strain to failure, and high resilience.[18,32]  
We chose hydrogels because they can be made highly conductive, transparent, 
biocompatible, and stretchable.[18,33] We formulated the hydrogel elastomer precursor 
analogously to the silicone by combining high molecular weight polyacrylamide 
(PAAM 5-6 million Mw; 92560, Sigma Aldrich) and acrylamide monomer (AAM; 
Sigma Aldrich) in deionized water and ethylene glycol (EG; Sigma Aldrich). We also 
used N,N’-methylenebisacrylamide (MBA; Sigma Aldrich) as the crosslinking agent 
and Darocur® 1173 (BASF) as the photoinitiator, ionic liquid (IL; 1-decyl-3-
methylimidazolium chloride, Sigma Aldrich) served as the conductive medium. As the 
hydrogel is optically transparent, we used fluorescently labeled monomer (FOA; 
Fluorescein O-acrylate, Sigma Aldrich) for visualization of the ink during printing. We 
found that using 14 wt% AAM, 5.6 wt% PAAM, 0.22 wt% MBA, 0.14 wt% Darocur® 
1173, 3.4 wt% IL, 0.1 wt% FOA, 56.2 wt% EG, and 20.3 wt% DI water resulted in the 
desired rheological and mechanical properties. 
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4.4 PHD Fabrication 
 
We fabricated silicone actuators using soft lithography as this process is simple and 
allows for rapid design iteration (details in SI). We then printed stretchable capacitors 
onto these pneumatic actuators as the skin of our PHD (Fig. 4.1, S4.1). First, we placed 
and leveled the prefabricated actuators on the bed of the 3D printer, then loaded the 
silicone and hydrogel inks into two separate syringes. By alternating layers of 
polyacrylamide and silicone inks we created planar arrays of capacitive sensors. The 
inks were exposed to high intensity UV radiation throughout the printing process. Once 
the capacitive skin was fully printed, no post exposure to UV light was necessary. We 
chose to overlay these sensors onto the actuators as an intuitive user interface to 
physically program the PHD; in addition, they enable us to detect the degree of actuation 
of individual chambers. Alternatively, if kinesthetic sensing is not needed, we can print 
the sensors anywhere, not necessarily on top of the actuators.  
 
4.5 Materials Characterization 
 
To be compatible with our pressure inputs (Δ𝑃"#$ ~ 270 kPa and Δ𝑃()*+ ~ 70 kPa) we 
tuned our materials to have viscosities less than 50 Pa×s at the shear rates for which we 
were printing (Fig. 4.2a). Both inks displayed pronounced shear thinning above a critical 
shear rate of ~0.1 s-1. This behavior indicates that above these shear rates, the entangled, 
long-chained polymers are aligning under the applied shear stress and will start to flow 
smoothly through micronozzles. Using Equation 4.1, we estimated the shear rate 
experienced by the ink at the nozzle walls during extrusion[34]:  
 	𝜸𝒘𝒂𝒍𝒍 = 	𝟑4𝒃𝟒 𝟒𝑸𝝅𝑹𝟑         (4.1) 
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where b is the inverse of the shear thinning exponent, Q = 𝝂𝝅𝑹𝟐 is the volumetric flow 
rate, v ~ 4 mm×s-1 is the print speed, and R is the nozzle radius. We determined the shear 
thinning exponent from our measured viscometry data to be 𝒏𝒉𝒚𝒅𝒓 = 0.287 and 𝒏𝒔𝒊𝒍 = 
0.496. We calculated the shear rate experienced by these fluids at the nozzle to be 𝜸𝒘𝒂𝒍𝒍𝒉𝒚𝒅𝒓	~ 157 s-1 and 𝜸𝒘𝒂𝒍𝒍𝒔𝒊𝒍 	~ 160 s-1. At these shear rates, the ink viscosities are 𝜼𝒉𝒚𝒅𝒓 ~ 
7 Pa·s and 𝜼𝒔𝒊𝒍 ~ 17 Pa·s. Ink elasticity is an important rheological parameter that can 
indicate whether ink will retain its printed shape before crosslinking. To determine the 
elasticity of these inks, we measured the shear elastic modulus (G¢) and viscous modulus 
(G¢¢) at a frequency of 1Hz (Fig. 4.2b). The polyacrylamide ink has a plateau elastic 
modulus of 𝑮𝒉𝒚𝒅𝒓𝟎  ~ 350 Pa and a yield stress of 𝝈𝒚𝒉𝒚𝒅𝒓~ 539 Pa, while the silicone ink 
has 𝑮𝒔𝒊𝒍𝟎  ~ 2250 Pa and a 𝝈𝒚𝒔𝒊𝒍~ 22 Pa. We found that both inks display a solid-like 
response (G¢ > G¢¢) at low shear stresses, which enables shape retention after extrusion 
and before being cured under UV illumination.  
 
The skin of the PHD must withstand large strains, yet deform at low stresses. As the 
mechanical properties of the skin are dominated by the silicone, we measured its tensile 
properties (Fig. 4.2c; details in SI). We also compared our printed material’s mechanical 
properties to that of cast silicone (Fig. 4.2c). At 100% strain, the printed and cast 
silicones have elastic moduli of 𝐸𝒑𝒓𝒊𝒏𝒕 ~ 73 kPa and 𝐸𝒄𝒂𝒔𝒕 ~ 109 kPa, respectively. The 
lower elastic modulus of the printed silicone may indicate that the high molecular 
weight polymer remains in a prestretched state due to shear alignment from extrusion.   
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Figure 4.2| Material characterization. (a) Viscometry and (b) oscillatory rheology 
data for insulating silicone and conducting polyacrylamide (PAAM) inks; (inset) 
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upturned vials of each ink demonstrate their elasticity. (c) Tensile data of 3D printed 
and cast silicone samples.  
 
4.6 Sensor Characterization 
 
Upon internal pressurization, the PHD’s chambers expand in area causing the surface 
to dome; commensurately, the sensor area overlaying the chamber also increases while 
its thickness decreases, resulting in a change in capacitance, ∆C. We recorded the ∆C 
using an LCR meter (Agilent 4284) while actuating a single chamber (Fig. 4.3a, left) 
using a fixed volume syringe pump in series with a pressure gauge. Here we show that 
this behavior is consistent with that of a continuously deforming circular parallel plate 
capacitor (i.e., 𝐶	~	𝐴𝑑QR, where A and d represent the electrode area and dielectric 
thickness, respectively). We first model the relationship between internal chamber 
pressure and the strain state of the sensor, and then reconcile that result with the 
expected change in capacitance as the sensor is stretched C(𝜆).  
 
To model P(𝜆), we employ three assumptions: (i) the membrane behaves linear 
elastically (Fig. 4.2c) with an elastic modulus, E, (ii) the undeformed sensor is a circle 
and upon actuation deforms into a spherical cap with a radius of curvature r, and 
deflection h, and (iii) the elastomeric membrane is incompressible giving rise to 
principle stretches of 𝜆R = 𝜆T = 𝜆, 	𝜆V = 	 𝜆QT, and principal stresses of 𝜎R = 𝜎T =𝜎, 𝜎V = 0. We first balance the forces from the internal pressure (𝑃) acting on the 
membrane with the induced reaction forces within it. 
 𝑃 ∙ 𝜋𝑟\T = 𝑇 ∙ 𝑠𝑖𝑛𝜃         (4.2) 
 𝑇 = 𝜎 ∙ 2𝜋𝑟\ ∙ 𝑡 
 𝑠𝑖𝑛𝜃 = 𝑟\𝑟  
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Where r0 is the radius of the undeformed sensor, T is the stretching force, t is the nominal 
thickness of the membrane (see Fig. S4.6). The pressure can therefore be expressed as 
follows: 
 𝑃 = Td∙&+ 	         (4.3) 
 
Given assumptions 4.2 & 4.3 we can relate	𝜆 to r, t, and t0 as follows:  
 eef = 	 Tg+(g+fh 	= 	 𝜆T										𝑎𝑛𝑑											 &&f = 	 𝜆QT	     (4.4) 
 
We now invoke a geometrical argument that relates r to r0 and h, both of which are 
measurable quantities. 
 𝑟T = 𝑟\T + 𝑟 − ℎ T        (4.5) 
 
Combining Equations (4.2)-(4.5) with Hooke’s law, 𝜎 = 𝐸(𝜆 − 1), yields the following 
relation: 
 𝑃(𝜆) = p&fq(rQR)(rhQR)s/h+fru 	       (4.6) 
 
The circular capacitive sensor is designed such that the in the fully actuated state (i.e., a 
hemisphere), it covers the underlying chamber completely. The nominal radius of the 
sensor, rC0, is thus larger than r0. To model the change in capacitance as accurately as 
possible, therefore, we bifurcate the capacitance equation into two parts – the first 
models the outer region that is bounded by rC0 and r0 (C0), and the center portion 
bounded by r0 (C1). Our equation for capacitance is: 
 𝐶 = 	𝐶\ +	𝐶R			        (4.7) 
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𝑤ℎ𝑒𝑟𝑒				𝐶\ = 𝜀+𝜀\ g(+yfhQ+fh)&yf 			      (4.8) 𝑎𝑛𝑑			𝐶R 	= 𝜀+𝜀\ Tg+(&y = 𝜀+𝜀\𝜋 +fh&yf 𝜆p	      (4.9) 
 
Combining relations in Equation 4.7 yields the relationship between 𝜆 and C: 
 
𝜆 = zQzf{|{fg|fh}yf
R/p
        (4.10) 
 
Finally, we substitute 𝜆(𝐶) in Equation 4.10 into Equation 4.6 to derive C(P). We solve 
for C(P) numerically in MATLAB to obtain the plot shown in Fig. 4.3a, left. Table 4.1 
lists the parameters used in the model. We observe that the predicted relationship 
between C and P is in general agreement with the measured values, confirming that our 
deformable capacitor follow C ~ A/d behavior. The slight deviation between the 
predicted and measured values at pressures > 25 kPa indicates that our bifurcation 
scheme could be further refined. 
 
Table 4.1. Model Parameters 𝑃 𝜆 𝜎 𝑟 𝑡 ℎ 𝑟\ 𝑡\ 𝐸 
Internal 
pressure 
Stretch Stress Radius Thickness Height 
Chamber 
radius 
Initial 
thickness 
Young’s 
modulus 
 𝐶 𝑟z\ 𝑡z  𝑡z\ 𝜀+ 𝜀\ 
Capacitance 
Initial Sensor 
radius 
Sensor 
thickness 
Initial sensor 
thickness 
Relative 
permittivity 
Dielectric 
constant 
 𝑟\ 𝑡\ 𝐸 𝑟z\ 𝑡z\ 𝜀+ 𝜀\ 
4.0 mm 3.7 mm 68.9 kPa 6.0 mm 0.33 mm 2.2 8.854×10−12 F⋅m−1 
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Next, we demonstrated the ability of the PHD to transduce external touch into an 
electrical signal by repeatedly pressing on a single sensor cell 99 times (Fig. 4.3a, right, 
S4.3). The average force delivered during the press of a sensor cell is approximately 2 
N (SI text), this force causes a detectable ∆𝐂 ~ 1 pF. As our goal was not to precisely 
measure the force a finger applies but to demonstrate the sensitivity to touch of the PHD, 
we used our own fingers instead of a machine; consequently, there is variation in the 
measured capacitance between the peaks.  
 
Additionally, using a pressurized air dispensing system, we actuated a single chamber 
of our pneumatic display while measuring the change in capacitance (Fig. 4.3b, 4.3c). 
We applied incremental pressures of air to the chamber, we then released the pressure 
and allowed it to deflate and repeated this cycle (Fig. 4.3c). We only tested up to 38 
kPa, above that pressure we start to observe deformation of the hydrogel electrode 
layers. No discernable capacitance change was observed until at least ∆P ~ 10 kPa was 
delivered to the chamber (Fig. 4.3b, 4.3c inset). Since we were inflating and deflating 
manually, the time for each actuation varied, thus the peak widths vary. The shapes of 
the peaks continue to evolve after initial pressurization due to the viscoelastic nature of 
the materials.   
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Figure 4.3| Sensor characterization. (a) Left, the measured (circles) and theoretical 
(line) capacitance as a function of inflation pressure. Right, repeatability of capacitor to 
sense stimulus when pressed by a finger. (b) Left to right, images of actuation at 
different applied pressures. (c) Capacitance dependence on inflation and deflation of 
actuator at increasing pressures; (inset) lower capacitance range magnified.  
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4.7 PHD Device Demonstration  
 
To demonstrate our printed sensor array’s ability to encode and read haptic information, 
we programmed a five-digit sequence into the PHD (SI text). We pressed on the 
individual capacitive buttons in an arbitrary sequence, sending a signal to an off-board 
microcontroller’s memory (Arduino Mega 2560). The microcontroller then played back 
the recorded sequence through pneumatic actuation of the individual chambers (Fig. 
4.4; supplemental video, SV1). We numbered the sensors one through four, and then 
punched in the code 2-4-3-2-1 (Fig. 4.4a). The PHD then individually inflated each 
underlying chamber associated with the sensor input (Fig. 4.4b). The PHD detected the ∆𝐂 of both the input stimulus (tactile sense) and output actuation (kinesthetic sense; Fig. 
4.4c). We note that the peaks from the input are sharp and output are broad due to the 
duration of the different events.   
 
 
Figure 4.4. PHD device demonstration. (a) Left to right, digital images of inputting a 
code (2-4-3-2-1) using finger to push on the sensor. (b) Left to right, pneumatic haptic 
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display playing back the same code (2-4-3-2-1). (c) Capacitance change of sensor as the 
code is being input, and then played back through pneumatic actuation. Please see SV1 
for video of programming and display sequence.   
 
4.8 Conclusion 
 
In summary, we have developed an inexpensive, hyperelastic, and printable skin for the 
sensory-motor coupling of soft machines. By tuning the rheological properties of 
elastomer precursors we formulated viscoelastic inks, which we patterned directly onto 
the actuators of our PHD. This capacitive skin enabled the PHD to detect a compressive 
force of ~ 2 N, and an internal pressurization of as low as ~ 10 kPa. As far as we know 
this is the first demonstration of a completely soft, feedback controlled haptic interface. 
As the majority of the mating surface between the skin and actuators is silicone, the 
device exhibited excellent adhesion and no delamination occurred even when high 
pressures (up to ~ 65.5 kPa) were applied to the actuating chambers. At these pressures, 
however, the inextensible sealing layer delaminated from the bottom of the PHD; this 
issue is general to PneuNets operated at high pressure.  
 
While the hydrogels used here have some amount of solvent and are thus somewhat 
sensitive to environmental conditions, solvent-free systems, such as the polyacrylic acid 
ones recently demonstrated,[35] could be used to mitigate this issue. While this is a 2D 
array of capacitors, 3D systems are possible with more complicated CAD design. It is 
also possible to miniaturize these capacitors by increasing the dielectric constant of the 
insulating material through the addition of fillers and the use of smaller nozzle diameters 
for decreased layer thickness. With these two steps we can more accurately replicate the 
natural ability of biological skin to localize touch sensations. The reliable, low cost, and 
flexible design space using DIW of tactile and kinesthetic sensors will improve robotic 
technologies—which are normally confined to perform repetitive tasks in structured 
environments (i.e. mobile industry)—by allowing humans to work more closely with 
machines in applications such as search and rescue and domestic care. This same sensor 
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technology could also improve the quality of life for amputees by enabling intuitive use 
and automatic adjustment of prosthetic devices.   
 
4.9 Supplemental Information 
4.9.1 Material System 
 
The silicone ink was formed by mixing and degassing 60 wt% Nuvasil® Loctite 5039 
and 40 wt% Wacker ® Semicosil 912 in a Thinky ARM-310 at 2000 rpm for 120s. The 
UV catalyst (Wacker ® Elastosil CAT UV) for Semicosil 912 was added at a 1:10 ratio 
prior to mixing. Due to the secondary moisture cure of Loctite 5039, this ink was used 
immediately.  
 
The polyacrylamide ink was formed by first mixing deionized water, ethylene glycol 
and acrylamide monomer (AAM) at room temperature. These constituents were 
magnetically stirred until the AAM was fully dissolved; at that point we slowly added 
polyacrylamide to the solution. After the solution was homogeneous, we added N,N’-
methylenebisacrylamide, Darocure® 1173 photoinitiator, 1-decyl-3-
methylimidazolium chloride ionic liquid, and Fluorescein O-acrylate.  
 
All chemicals were used as received.  
 
4.9.2 Rheological, Mechanical, and Electrical Measurements 
 
Oscillatory rheometry was performed on both ink solutions using a cone (25mm, 2º) 
and plate geometry at a frequency of 1 Hz and an oscillatory stress from 0 to 900 Pa to 
determine the elastic modulus (G¢), loss modulus (G¢¢), and yield stress (𝜎)) of the 
printable ink. Viscometry was performed on both inks as well, from shear rates of 0 to 
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103 s-1. All data were taken using cone and plate geometry with ~0.5 ml of material on 
a TA Instruments Discovery Hybrid Rheometer DHR3 rotational shear rheometer.  
 
We performed uniaxial tensile tests on a Z010 Zwick Roell using a 20 N load cell at a 
strain rate of 3.33 mm/s. We tested at least six repetitive samples of both printed and 
cast silicone. After printing and casting large rectangular geometries of silicone 
elastomer precursor, we used a razor blade to cut out six straight, rectangular test 
samples with approximate dimensions of 40x7x0.6mm.  
 
We measured the electrical performance of the ionic liquid containing hydrogel using a 
Cascade CP06 Four Point Probe with four in-line probe tips and a Keithley 2400 Source-
Meter. We prepared two thin (~25x25x1.3 mm3) film specimens of the conducting 
hydrogel. The four-point probe system was configured for single resistance 
measurements by sourcing 0.001 A of current and measuring voltage. We measured 
voltage five times in three locations of each film.  Using a probe spacing of s = 1.59 mm 
and an average film thickness of t = 1.3 mm, we calculated the thickness correction 
factor, a, for our measurements using the following equation[36, 37]:  
 
For t/s > 0.5: 𝑎 = 	 RR4	f.hh(})s.  
 
We then calculated the conductivity by taking the inverse of the following general 
expression for resistivity:  
 𝜌 = 	𝑠𝑎2𝜋 𝑉𝐼  
 
We calculated a conductivity of σ ~ 10.8 mS/m for the ionic liquid containing hydrogel.  
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4.9.3 Direct-Write Assembly of Sensors 
 
The ink was loaded into a syringe with an attached stainless steel dispensing tip in place. 
We created planar arrays of sensors by layering the polyacrylamide and silicone inks. 
Once the sensors were patterned, we printed an encapsulating layer of silicone ink. 
While patterning the ink materials, we exposed them to 5 mW cm-2 using a UV lamp 
(Omnicure ® S1500; Excelitas) with a wavelength range, λ = 320 - 500 nm. The part 
was fully cured after printing and not post-printing curing step was needed.  
 
4.9.4 PHD Actuator Fabrication  
 
The actuators of the PHD are composed of a highly resilient silicone elastomer (Ecoflex 
00-30; Smooth-On, Inc.), with an elastic modulus of ~ 40 kPa at 100% strain and 
ultimate strain of 𝛾$%$& > 900%. We fabricated these devices using soft lithography 
from 3D printed molds. We designed a mold for the pneumatic actuators and then 
fabricated them in Rigid Opaque Blue material (Fig. S4.4, VeroBlue RGD840; 
Stratasys, Inc.) using a 3D printer (Objet24; Stratasys, Inc.). We blended green pigment 
(Silc Pig ®; Smooth-On, Inc.) into a matrix of uncured Ecoflex 00-30, then degassed 
the polymeric melt and poured it into the mold. We cured the Ecoflex for 60 min at 80 
ºC. We removed this part from the mold and layered it onto an inextensible composite 
sheet of Ecoflex and carbon fiber veil (Fibre-Glast, Inc.). We glued the extensible layer 
to the inextensible one using a thin layer of Ecoflex precursor.  
 
Next, we inserted electrical wires (1 mm outer diameter) and pneumatic tubing (1 mm 
inner diameter) into their respective channels (Fig. 4.1a). Finally, we filled the well 
surrounding the electrical wiring with the conductive polyacrylamide ink. This ensured 
excellent contact between the electronic (wires) and ionic (polyacrylamide hydrogel) 
conductors. This also allowed seamless electrical contact to the capacitive sensors, 
which would be printed on the surface of this Ecoflex part. We chose a haptic display 
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design with four actuators because it yields 16 unique combinations with a simple on-
off motif for tactile communication yet is also a compact design. This specific geometry 
considered hand and finger ergonomics, as well as integration of pneumatic feed tubes 
and electrical wiring. 
 
4.9.5 PHD Controls 
 
We connected the electrical wiring of our haptic device to the off-board microcontroller 
(AT Mega 2560): the ground plane of each sensor to the ground of the microcontroller 
and each of the four sensor channels to four separate digital input ports on the 
microcontroller (Fig. S4.5). The outputs of the four sensors were read and processed by 
the Arduino’s Capacitive Sensing Library. This library measures capacitance by 
counting the amount of time it takes for the digital pin to change states (HIGH to LOW, 
or LOW to HIGH voltage) and outputting the corresponding digital timestamp. This 
digital timestamp is proportional to the capacitance via the time constant 𝜏 (𝜏 = 𝑅 ∙ 𝐶), 
where R is resistance and C is capacitance. Since our capacitance measurements were 
derived from timestamps, it was necessary to calibrate the measurements. Though this 
method was not the most accurate capacitive measurement option, it allowed us to 
analyze the capacitance values of all four sensors simultaneously and in real-time.  
 
We wrote a simple program to continuously monitor the capacitance values of each of 
the sensors. When the minimum threshold value for capacitance (25 pF) was met by a 
sensor, we considered this a ‘button-press’ and the microcontroller stored that sensor’s 
identification (ID; 1 through 4) into a First-In-First-Actuated (FIFA) queue of length 
five. After 5 unique button presses, our control algorithm switched from ‘sensing’ mode 
to ‘actuation’ mode. 
 
Using four separate digital output ports, we connected the microcontroller to four 
solenoid valves (Parker X-Valve). These valves controlled the pressure inside the four 
actuation chambers via the pneumatic tubing. The pressure in each chamber was 
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increased by 35 kPa with a control signal of HIGH and reduced back to atmospheric 
pressure with a control signal of LOW. During ‘actuation’ mode, the microcontroller 
was set to transmit the HIGH signal on each of the output channels corresponding to the 
IDs stored in the FIFA queue (generated during ‘sensing’ mode). Each output signal of 
HIGH lasted for duration of 2 seconds before moving on to the next ID in the queue. 
Upon completion of the final actuation in the sequence, the microcontroller would revert 
back to ‘sensing’ mode to receive a new sequence of five button presses. 
 
The average response time of each of these chambers was approximately 120 ms. This 
value is a combination of the minimum response time of the solenoid valves we used 
plus the average time it takes for the pressure of the chamber to increase to ~ 28 kPa.  
 
4.9.6 Average Force of Finger Press  
 
We pressed on a precision balance (Mettler Toledo MS403S) and recorded the amount 
of force reported. We repeated this ten times over four trials and then calculated the 
average applied force by the finger used in the experiments to be ~ 2 N. 
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Figure S4.1| Schematic of PHD. (a) Top down schematic of PHD with overlaying 
capacitive skin. The four underlying pneumatic chambers are visible with the four 
overlaying sensors. Pneumatic and electrical lines are also shown. (b) Side view the 
PHD with overlaying capacitive skin. Two pneumatic chambers are shown with two 
overlaying sensors. (c) Expanded view of printed sensor, with printed electrodes in gray 
and printed insulator in black. The top layer of silicone is slightly thicker to ensure good 
encapsulation of sensors.   
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Figure S4.2| Uniaxial tensile test of conductive, polyacrylamide hydrogel.  
 
 
Figure S4.3| [99] repetitive presses of sensor with finger. 
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Figure S4.4| Soft lithographic mold for pneumatic haptic display.  
 
 
Figure S4.5| Off-board microcontroller configuration. 
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Figure S4.6| Free body diagram of actuator-sensor pair during pneumatic 
pressurization.  
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CHAPTER 5      
CONCLUSION  
 
3D printing has been utilized to create a wide variety of anatomic models and tools for 
procedural planning and training, but has yet to be used to create permanent, soft 
endocardial implants due to the unique challenges regarding hemocompatibility and 
durability of the printed materials. Here, I presented an approach for the rapid 
prototyping of patient-specific cardiovascular occluders via 3D printing and static 
molding of inflatable silicone/polyurethane balloons derived from volume rendered 
computed tomography (CT) scans. This approach provides custom-made implants 
fabricated using high quality, durable, and hemocompatible elastomeric materials.  To 
illustrate the utility of this approach, I demonstrated the use of these devices for 
occlusion of the left atrial appendage (LAA), a structure known to be highly variable in 
geometry, and the primary source of stroke for patients with atrial fibrillation.  I 
described the design workflow, fabrication, and deployment of these patient-specific 
LAA occluders as a proof-of-concept, and show their efficacy using 3D printed 
anatomic models, in vitro flow loops, and an in vivo large animal model. 
 
Finally, I presented work on synthetic sensors that can be 3D printed, using direct ink 
writing (DIW) onto soft, fluidic elastomer actuators (FEAs). This 3D printing technique 
used two inks—one that was an ionically conductive hydrogel and another that was an 
electrically insulating silicone—which was patterned and photopolymerized into 
stretchable capacitive sensors. In that paper, the sensors were used to enable tactile 
sensing and kinesthetic feedback in a pneumatically actuated haptic device. The 
capacitive skin enabled the device to detect a compressive force from a finger press of 
~2 N, and an internal pressurization of as low as ~ 10 kPa. By using a 5-axis conformal 
printer, and real-time surface mapping, it may be possible to directly print these soft 
sensors onto the surface of pre-fabricated left atrial appendage occluders.     
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APPENDIX - Second author publications   
APPENDIX A 
SELECTIVE MINERALIZATION OF TOUGH HYDROGEL LUMENS FOR 
SIMULATING ARTERIAL PLAQUE 
 
Lihong Lao, Sanlin S. Robinson, Bryan Peele, Huichan Zhao, Benjamin C. Mac Murray, 
James K. Min, Bobak Mosadegh, Simon Dunham, and Robert F. Shepherd, Advanced 
Engineering Materials. 2016, 19, 1, 1600591 
 
A.1 Abstract 
 
Recently, computational fluid dynamics (CFD) has been developed for modeling 
coronary artery pressure and flow, and predicting surgical outcomes for coronary artery 
disease (CAD). For accurate modeling, artificial arteries (phantoms) with occlusion 
need to be produced and used for measurement of fluid flow. This article demonstrates 
progress towards that goal—the molding of a hydrogel lumen using a tough 
polyacrylamide with regions selectively mineralized with calcium phosphate to 
fabricate phantoms that mimic plaque buildup. By tuning the degree of mineralization 
using conditions such as calcium concentration ([Ca2+], 0.4 M to 2 M), and 
crystallization time (tc, 1 to 4 weeks), we control the extent of lumen occlusion. These 
synthetic, occluded lumens significantly reduce pressure (up to DP~7.79 kPa) during 
fluid flow compared to the non-calcified hydrogels (DP~1.24 kPa). Additionally, image 
and chemical analysis as well as compressive mechanical testing are performed to 
determine the effect of synthesis conditions on the composite’s mechanical properties. 
For comparison to real arteries, we also present dynamic mechanical analysis of human 
aortic tissue. 
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A.2 Introduction 
 
Coronary artery disease (CAD) is responsible for more than one third of all deaths in 
the U.S. and ~1.2 million hospitalizations annually.[1] CAD is characterized by the 
buildup of plaque in the coronary arteries, restricting blood flow, and thus oxygen 
perfusion to the myocardial tissue of the heart.[1, 2] Plaque is the region of thickening on 
the inner lining of the artery, which may result from intimal proliferation of smooth 
muscle cells, or formation of fat and inflammatory cells inside the intima.[2-4] As plaque 
grows it accumulates scar (fibrous) tissue and abundant calcium. Since crystallized 
calcium is hard, the plaque is often referred to as "hardening of the arteries”. [3]  
 
Both qualitative and quantitative assessment of how blood flows through these restricted 
pathways (stenoses) are used to assess the treatment of CAD in a patient. For example, 
computed tomography (CT) is as a non-invasive option for qualitative coronary 
angiography which now allows for acquisition of virtually motion-free images at 
isotropic spatial resolution of 400 µm.[5] Fractional flow reserve (FFR) is a quantitative 
assessment with a measurement that reports the potential decrease of coronary flow in 
a diseased artery, and thereby identifies a stenosis during coronary angiography and 
cardiac catheterization.[6] Due to the breadth and complexity of diagnostic tools, 
difficulty of patient access, and the variation in manifestations of the disease state itself 
it is useful to assess the flow dynamics and the performance of diagnostic and 
therapeutic medicine in controlled settings. Towards that goal, computational fluid 
dynamics (CFD) modeling has been developed that allows for modeling of coronary 
artery pressure and flow.[7, 8] Using CFD for diagnostics, however, remains uncertain 
when assessing complex flow and pressure calculations in plaque-laden arteries.[7, 9] 
Furthermore, simulating treatment or testing medical diagnostic tools cannot, presently, 
be done virtually.   
 
For accurate modeling and validation, artificial arteries (phantoms) were produced and 
used for direct visualization of fluid through a stenosis.[10-16] Most prior designs have 
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been composed of inorganic materials such as glass,[10, 11] which do not match the 
material properties of soft tissues in real human arteries. Silicone-based elastomeric 
materials have also been widely used,[12, 13] such as Elastrat Sarl (Switzerland),[12] to 
construct phantom models; however, the phantoms were usually mono-layered and 
single material, and therefore did not reproduce the wall architecture or chemistry 
present in plaque. Other attempts have also been made to directly print vascular 
phantoms by 3D Polyjet printers, using either hard (acrylic) or elastomeric materials 
(polyurethane),[14] or by hydrogel molding, using polyvinyl alcohol (PVA).[16]   In 
several cases, stenotic geometries were evaluated showing that these features will 
influence flow and deformational mechanics of the arterial wall.[15, 16] While these 
studies highlighted the importance of the mechanics of the stenosis, the materials 
(silicones and PVA) used were much softer than that of coronary calcium, which are 
orders of magnitude stiffer than healthy coronary tissue.[17] Ideally, these phantoms 
would represent a patient’s specific arterial geometry, mechanics, and material 
properties for use in diagnostics and predicting the outcomes of invasive procedures.  
 
In order to accurately simulate a patient’s specific coronary arteries, we must be able to 
replicate both their shape and mechanical properties.[8, 18] Recently, hydrogels—swollen 
networks of hydrophilic polymer—have emerged as a viable material solution for 
mechanical devices. For instance, polyacrylamide (PAAm)-based hydrogels have been 
widely used as elastomeric matrices due to their high toughness and extensibility, as 
well as optical transparency.[19-21] With these properties, these hydrogel networks could 
provide support for liquid flow as a synthetic artery and have the potential for 
calcification to mimic the process of plaque formation that sometimes leads to CAD. In 
this paper, we describe a new approach to fabricate synthetic artery phantoms using 
tough polyacrylamide hydrogels that have been selectively mineralized to mimic plaque 
formation, both chemically and mechanically. We report compression tests to evaluate 
the mechanical properties of the calcified hydrogels, and image and chemical analysis 
of the calcium phosphate crystallization. Finally, we assessed the potential of these 
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synthetic lumens to be used as arterial phantoms via fluid flow at the rates and pressures 
typical of the human cardiovascular system. 
 
A.3 Results and Discussion 
 
We synthesized mineral-incorporated polyacrylamide hydrogels via 
photopolymerization and repeated mineralization in 0.4 M or 2 M calcium and 
phosphate solutions (Figure SA.1a, Supporting Information). Figure A.1 compares the 
SEM morphology of the bulk polyacrylamide hydrogels before and after repeated 
mineralization. The neat hydrogels showed a smooth and interconnected porous 
structure (Figure A.1a), consistent with prior reports.[22, 23] The mineralized samples, 
however, transformed from transparent to white from light scattering due to surface 
roughening and an index of refraction mismatch between hydrogel and mineralized 
crystal growth (Figure A.1b-f and Figure S A.1b, Supporting Information). The degree 
of crystallization and crystal morphology varied according to immersion time, tc and 
solution concentration, [Ca2+].[24, 25] For short immersion times (one week) in low [Ca2+] 
concentrations (0.4 M), fine needle-like (acicular)  crystals were formed along the pore 
walls (Figure A.1b, indicated by arrows); Energy dispersive X-ray spectroscopy (EDS) 
confirmed that these crystals are calcium phosphate, as indicated by calcium (Ca) and 
phosphorus (P) elements (Figure S A.1c, Supporting Information). When it was further 
immersed in the solution, repeatedly for four weeks, the minerals grew into flake-like 
(platy) crystals with a higher density (Figure A.1c). Increasing the ionic concentration 
of the solution to 2 M accelerated the mineral growth. As shown in Figure A.1d, finer 
and denser minerals were found in the gel after one week compared with those 
mineralized in 0.4 M solution (Figure A.1b). A still longer repeated incubation (four 
weeks) made minerals even denser, leading to a complete coverage of the gel by a thick 
layer of crystal needles (Figure A.1e). The morphology was analogous with what has 
been observed in the prior reports,[24, 26] and coronary plaque with tissue calcification.[27] 
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The increasing surface mineralization from the prolonged conditioning time is primarily 
due to surface nucleation on top of the already formed calcium phosphate crystals.[24, 25] 
We confirmed that the density of mineral on the interior of the gel is lower with a graded 
transition (Figure A.1f and Figure S A.1b, Supporting Information), likely due to the 
mineralized surface reducing diffusive transport of ionic species.[24] This is likely the 
reason for the drill-like appearance in the center of some hydrogel samples, especially 
for those mineralized in higher [Ca2+] and longer tc (the inset images in Figure A.1d, e). 
Therefore, the result is a gradient transition from a high elastic modulus mineral to a 
low elastic modulus hydrogel.  
 
The chemical structures of the mineralized hydrogels were further verified by FTIR 
spectra, as shown in Figure A.2. In the neat polyacrylamide hydrogel (Figure A.2a), 
there were three characteristic peaks of the amide groups: 1652 cm-1, 1606 cm-1 and 
1417 cm-1 (denoted by asterisks), which represented –C=O stretching vibration of the 
amide (I) group, –NH2 bending vibration of amide (II) group and –CN stretching 
vibration of amid group, respectively.[28] The broad peak between 3600-3000 cm-1 is 
attributed to the O–H of water, NH and CH2 stretching of polyacrylamide.[26] The peaks 
at 2850 cm-1 and 1448 cm-1 were also due to CH2 stretching and scissoring vibration, 
respectively.[26, 28] Because of the initial incorporation of phosphate ions, the neat 
hydrogel also has two characteristic peaks at 1066 cm-1 and 953 cm-1 (denoted by hollow 
triangles), which were stretching and bending of PO43-, respectively.[25, 26] The peak at 
1319 cm-1 may attribute to surface carbonate ions likely due to the absorption of 
atmospheric CO2.[26]  
 
When the hydrogel was repeatedly mineralized in calcium and phosphate solutions, 
there were noticeable decrease of amide peaks and increase of phosphate peaks (Figure 
A.2b-e), especially at 1652 cm-1 and 1066 cm-1 (or 1024 cm-1, a slight shift in some 
samples), respectively. When calculating their relative strengths (peak height of PO43- 
at 1066 cm-1 or 1024 cm-1 and peak height of amide at 1652 cm-1), we found they 
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increased with [Ca2+] and tc. These results were consistent with the growth trend of the 
minerals in the hydrogels (Figure A.1). 
 
The mechanical and material properties of plaque are dramatically different than arterial 
tissue.[17] Though plaque stretches circumferentially during blood pressure pulsation, it 
is also significantly compressed. Therefore, compressive tests are widely used to 
determine the mechanical behavior of atherosclerotic plaque tissues.[29, 30] To simulate 
the compressive mechanical properties of human arteries, we first measured the storage 
modulus (𝐸′) of healthy aortic tissue. Using dynamic mechanical analysis (DMA), we 
found a relatively frequency independent E’ for healthy arteries that vary from 𝐸′~0.1 
MPa to 𝐸′~2.5 MPa (Figure A.3a).  For example, in human artery 1 and 3, E’ was higher 
along the longitudinal cuts (𝐸′~0.6 MPa and 𝐸′~1.1 MPa, respectively) than by 
circumferential cut (𝐸′~0.1 MPa and 𝐸′~0.5 MPa, respectively). Prior reports 
showed the dynamic moduli varied in different parts of human arterial tissues and in 
patients with different ages, e.g. ~0.5-3 MPa in carotid, thoracic and abdominal 
aortae,[31] ~0.5-7 MPa in iliac and femoral arteries,[31] and ~13.5 MPa for human aortic 
valve tissue.[32] Our results of healthy aortic tissues fall within these ranges.  
 
Our synthetic hydrogel (PAAm) demonstrated a similar frequency insensitive storage 
modulus, with the pure PAAm having a 𝐸′~29 kPa, well below that of fixed human 
arteries. When the gels were mineralized in a low ionic concentration ([Ca2+]~0.4 M) 
for one week the storage modulus increased to 𝐸′~70 kPa, similar to the lower end 
of human arterial tissue. By controlling the immersion time (tc) and ionic concentration 
([Ca2+]), we were able to tune the storage modulus of the synthetic hydrogel composite 
over the entire span of natural tissue. For example, increasing the ion concentration from 
0.4 M to 2 M brought a significant increase of the dynamic modulus by ~75X in one 
week of mineralization (𝐸′~70 kPa vs. 𝐸′~4.74 MPa, significance level p<0.05), 
and extending the immersion time from one week to four weeks brought a ~150X 
increase in 0.4 M ion solution (𝐸′~70 kPa vs. 𝐸′~9.37 MPa, p<0.05), and ~3X 
in 2 M ion solution (𝐸′~4.74 MPa vs. 𝐸′~15.81 MPa, p<0.05), respectively.  
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The difference of the moduli between the four week mineralized hydrogel in the 0.4 M 
and 2 M solutions was insignificant (𝐸′~9.37 MPa vs. 𝐸′~15.81 MPa, p>0.05), 
as demonstrated by the overlapping of the top two curves. Both mineralization processes 
resulted in significantly higher storage moduli than healthy human arteries (p<0.05; 
sample size, n=3).  
 
To determine what ranges of mechanical properties our synthetic materials can achieve, 
we performed monotonic compression tests over large strain ranges, as shown in Figure 
A.3b. The neat hydrogel showed an elastic modulus, 𝐸~29 kPa, similar to that from 
the dynamic frequency sweep (Figure A.3a). Increasing both the ion concentration and 
mineralization time led to increased elastic moduli; however, the ultimate strain, 𝜀%$&, 
was commensurately reduced. For example, samples mineralized in 0.4 M solution for 
four weeks had 𝐸~2.2 MPa and 𝜀%$&~0.13, and exposure to 2 M for four weeks 
resulted in a compressive storage modulus 𝐸~2.4 MPa and 𝜀%$&~0.06.  
 
Prior reports on the mechanical properties of plaqued arterial tissue yield highly variable 
results.[33-35]  For instance, a dynamic stiffness of 2.27±1.0 MPa has been observed for 
the calcified caps in human aortic plaques under a compression level of 1.2±0.2% and 
frequency ranging from 0.05 Hz to 10 Hz, 4-5 times stiffer than cellular caps.[33]  In a 
static compressive mechanical test, non-fibrous human aortic plaque has been reported 
with a compressive modulus of 41±18 kPa under 24% strain, while that of fibrous and 
calcified plaques increased to 82±33 kPa (under 11% strain) and 355±245 kPa (under 
3% strain), respectively.[34]  Compressive behavior of calcified samples in carotid artery 
plaque was also reported with an average modulus of 140 kPa and 2.3 MPa at 5% and 
20% compression, respectively.[35] These demonstrated our mineralized hydrogel has 
the potential to reach the stiffness of real human arteries with or without plaques under 
different controlled conditions. 
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We molded the tough hydrogel into synthetic lumens by UV curing the polyacrylamide 
in a transparent cylindrical mold (Figure S A.2a, Supporting Information). The lumens 
had an inner diameter, an outer diameter, and a total length of 2.74±0.15 mm, 6.48±0.20 
mm and 60 mm, respectively (Figure A.4a). The inner diameter was similar to the mean 
value of the real coronary arteries from patients with acute coronary syndrome imaged 
via intravascular ultrasound.[36] The selective mineralization was realized by immersing 
the middle region of the lumen in the mineralization solution (0.4 M or 2 M) while both 
ends were submerged in deionized water (Figure A.4b), these fluids were renewed every 
24 hours. Figure A.4c shows a lumen after mineralization in 0.4 M solution for four 
weeks (images of samples with short tc can be found in Figure S2d,e, Supporting 
Information). We found the middle part calcified to completely white, while the sides 
remained transparent. The mineralization also occurred across the circumference of the 
lumen as indicated in Figure A.4d (left). Additionally, we found a swelling of the non-
mineralized portion of the lumen during mineralization, i.e. the total length increased to 
L~74 mm (Figure A.4c), with the initial Lo~60 mm (Figure A.4a and inner tube in Figure 
A.4c); the circumferential wall also swelled and led to a higher expansion of the outer 
diameter (9.63±0.30 mm, ~48.6%) and shrinkage of the inner diameter (1.97±0.07 mm, 
~28.1%) for the mineralized region (Figure A.4d, left) compared with the non-
mineralized sides (Figure A.4d, right). In this view, an occlusion with ~33.0% nominal 
stenosis severity (the reduction of diameter)[16] has been selectively formed in the 
mineralized lumen.  
 
To demonstrate the potential application of the mineralized hydrogel lumen as a 
phantom for a plaque occluded artery, we set up a fluid flow system to test the pressures 
during flux through the lumens (Figure A.5a). We cut the samples into 50 mm long 
lumens with a 10 mm center section that we mineralized to various extents, and then 
inserted them into fittings (Figure A.5b) connected to a water source. Figure A.5c shows 
the difference (DP) between the inlet (P1) and outlet pressures (P2) through various 
hydrogel lumens with the water flow (Q) from 37.9<Q<252.4 mL min-1; we chose the 
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maximum flow rate to approximate blood flow in the human internal carotid artery, 
Q~250 mL min-1.[37, 38]  
 
Overall, we found pressure drops across hydrogel lumens increased as the flow rate 
increased (Figure A.5), similar to measurements in natural arteries.[38] There was a 
strong correlation between the pressure drop, DP (P2-P1), across the lumen and degree 
of mineralization. The neat hydrogel lumen recorded a small DP ~1.24 kPa at the 
maximum flow rate. The one-week mineralization in 0.4 M solution did not bring 
significant difference in the pressure drop compared with the neat lumen (p>0.05), while 
the pressure driven flux for the gel mineralized in 2 M solution significantly deviated 
from that of the neat hydrogel at a higher flow rate (>150 mL min-1; p<0.05). The drops 
were even more pronounced for lumens with a longer tc of four weeks: under a 
maximum flow of 252.4 mL min-1, the gel mineralized in 0.4 M solution generated a 
DP~5.58 kPa, and the one in 2 M solution led to a DP~7.79 kPa, about six times that of 
the non-mineralized neat sample.  
 
In our model, the pressure drop was generally produced due to the stenosis of the 
lumen.[39] The difference of mechanical toughness between the middle mineralized 
region and two non-mineralized sides also contributes to the flow rate across the lumen. 
When blood flows through a natural lumen it expands; however, stiff plaque prevents 
this expansive deformation and may generate a local pressure difference.[40, 41]  For 
example, prior CFD simulations of blood flow through a 60% diameter-reducing 
stenosis has been reported to generate a pressure drop of 2.53 kPa (19 mm Hg) under a 
hyperemic flow of  216 mL min-1.[7] Another simulation across a 10 mm long 67% 
diameter-reducing carotid artery stenosis has also been reported to generate pressure 
drops ranging from severe 7.73 kPa (58 mm Hg) to mild 1.60 kPa (12 mm Hg) 
depending on the positions and shapes of the distal end of the plaque, under a mean 
blood flow of ~250 mL min-1.[38] Figure A.5c demonstrates that our synthetic 
mineralization can achieve these features and be appropriately used for phantoms to 
complement CFD analysis and aid in modeling and predicting surgical outcomes for 
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CAD procedures. Our preliminary results are comparable with a prior study, where a 
pressure drop of 1.3-10.7 kPa (10-80 mmHg) was recorded with a flow rate of 30-210 
mL min-1 along a synthetic stenosis model (with a higher nominal stenosis severity of 
70%) made of PVA hydrogel as both lumen and occlusion.[16]  
 
A.4 Conclusion 
 
In summary, we have developed a mineralized hydrogel system as a synthetic model for 
coronary arteries with plaque buildup. By tuning the mineral concentration, [Ca2+], and 
crystallization time, tc, we controlled the mechanical properties and degree of occlusion 
of the hydrogel lumens. The occluded lumen generated large pressure drops and 
commensurately lower flow rates compared with non-mineralized hydrogels; these 
effects could be tuned to comparable or more severe conditions than those related to 
natural arterial occlusions. Due to the similarity of our synthetic material constituents 
to natural ones, these phantoms are likely better simulations for coronary calcification 
than previous alternatives. Since the mechanical properties of these hydrogel-based 
arteries mimic that of diseased ones in vivo, they could be used as a learning tool for 
clinical fellows to practice procedures (e.g., angioplasty, coronary artery bypass grafting 
(CABG), stent), or as an in vitro system to develop interventional or implantable 
devices. Furthermore, the molding technique allows these arteries to be fabricated in 
patient-specific geometries that will be useful for interventionalists and surgeons to plan 
for individual procedures.   
 
Future improvement of our synthetic lumens will better mimic the shape and exact 
material properties of patient specific arteries for improved phantom fidelity. For 
example, the hydrogel lumen and the flow test could be better designed to simulate real 
artery behavior, such as molding branched arteries, replacing water with blood formula 
for the pressure test, and applying a pulsatile flow.[12, 13] Flow testing should also be 
performed on these materials using conventional medical imaging (CT, 
echocardiogram, and MRI) to assess their ability to simulate realistic tissue response 
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and not just a time and position averaged flow response.  Finally, though not shown in 
this paper, it would be possible to accelerate the crystal growth and reduce the time 
required to cause the occlusion by further shortening the cycling time (tc) and increasing 
calcium concentration ([Ca2+]). 
 
A.5 Experimental Section  
 
A.5.1 Hydrogel preparation 
 
The polyacrylamide hydrogels were synthesized using the following protocol.[20, 26] 
Acrylamide monomer (AAm; Sigma, A8887) was dissolved in deionized water, with 
AAm fixed at 2.2 M. The solution was subsequently mixed with a crosslinker, N,N′-
methylene bisacrylamide (MBAA; Sigma, M7279) set at 0.01 the weight of AAm,  a 
photoinitiator, Darocur® 1173 (BASF) was added at 0.15 wt% in solution, and 
ammonium phosphate dibasic ((NH4)2HPO4; Sigma, 215996) was used at 0.4 M in 
solution. We stirred the solution overnight, at room temperature, until the solution was 
homogeneous and then poured it into a paper cup mold (diameter~62 mm, height~10 
mm) with thickness of 3 mm and cured it via exposure to 365 nm light (350 W; 
OmniCure® S1500 A UV light curing system, Lumen Dynamics Group Inc) for 5 
minutes. The sample was kept in a refrigerator (4 °C) overnight so the reaction could 
approach completion while limiting desiccation.[42] 
 
A.5.2 Mineralization 
 
To mineralize the hydrogels, we immersed them in a solution containing 0.4 M or 2 M 
calcium chloride (CaCl2; Sigma, C1016) at room temperature.[24, 26] After 24 hours, the 
samples were extensively washed with deionized water to remove surface precipitates 
and immersed in a fresh solution containing (NH4)2HPO4 with concentrations of 0.4 M 
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or 2 M, respectively. We repeated these steps from one to four weeks for increasing 
degrees of mineralization (Figure S1a, Supporting Information). After the desired time, 
we washed the mineralized gels and wipe-dried the surface for further analysis.  
 
A.5.3 Morphology analysis 
 
We used scanning electron microscopy (SEM) to observe the microstructure of the neat 
and mineralized PAAm hydrogel samples. To prepare the samples for the vacuum 
conditions of the SEM, we freeze dried them using liquid nitrogen.[22] We then coated 
the samples with a thin layer of gold palladium and observed them on a Tescan Mira3 
FESEM. We used energy-dispersive X-ray spectroscopy (EDS) for elemental analysis.  
 
A.5.4 Chemical analysis 
 
We used a fourier transform infrared (FTIR) spectrometer (Nicolet Magna-IR® 560) to 
check the chemical composition of the freeze-dried neat and mineralized PAAm 
hydrogels. We cut a thin piece (~1 mm) of each sample for testing, and set the scan 
range to 4000-400 cm-1 and resolution to 2 cm-1. 
 
A.5.5 Mechanical test  
 
We measured the mechanical properties of neat and mineralized hydrogels using 
dynamic mechanical analysis (DMA; TA Instruments, Q800) equipped with two 
parallel compression platens (12.7 mm in diameter). The samples were ~6.5 mm in 
diameter and ~3.0 mm in height (measured automatically via DMA software). We tested 
five parallel specimens for each set of samples. To obtain the dynamic storage moduli 
(𝐸′) of the hydrogels, the samples were compressed by preloading to 0.1 N contact force 
and applying a frequency sweep from 1 to 10 Hz using 0 to 2% compressive strain, [L0-
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L]/L0, where L0 is original specimen length and L is ultimate specimen length.  We also 
measured the stress vs. strain relationship in monotonic compression using the DMA by 
preloading hydrogel samples to 0.1 N and compressing at a force ramp rate of 3 N min-
1 with an upper force limit of 18 N. Compressive elastic moduli (𝐸) were calculated 
from the 0 to 4% stress-strain curves. For convenience of expression, the neat and 
mineralized hydrogel was notated as NH and MH in the DMA curves, respectively. 
 
A.5.6 Arterial DMA test 
 
We also tested fixed, human aortic tissue (cadaveric, Weill Cornell Medicine) in tension 
using DMA. To ensure the samples would not dry out during testing we equipped the 
instrument with a small chamber that we filled with saline solution. In addition, we 
modified the clamps of the DMA with sandpaper to better grip the tissue specimens. 
Using a #11 scalpel, we cut circumferential and longitudinal samples from a large 
rectangular aortic specimen (the original tubular specimen had already been opened 
when we received them). We applied a pre-load force of 0.1 N, and then performed a 
frequency sweep from 0.1 to 10 Hz. The sample along longitudinal and circumferential 
cut was notated as HA (LC) and HA (CC) on the DMA curve, respectively. 
 
A.5.7 Selectively mineralized lumens 
 
Using polyacrylamide, we molded synthetic lumens by casting the acrylamide solutions 
into a transparent cylindrical mold (the inner diameter, outer diameter and total length 
was ~2.7 mm, 6.5 mm and 60 mm, respectively; Figure S2a, Supporting Information). 
To ensure the uniform crosslinking, we initially kept the mold with the solution 
vertically standing, after ~1 min curing, we flipped the mold to be horizontal and rotated 
it under the light so that all the parts of the tube would be exposed to the light. We then 
 149 
placed the molded lumens into a 3D-printed mold designed to isolate and selectively 
mineralize a segment of the hydrogel (Figure S2b, Supporting Information). The three 
segment lengths (left, middle, and right) of the mold were 25 mm, 10 mm, and 25 mm, 
respectively. The middle section was initially filled with calcium chloride solution (0.4 
M or 2 M) to mineralize the middle part of the lumen, the left and right sections were 
filled with deionized water. The joints of the mold assemblies were completely sealed 
by silicones (Ecoflex 00-30; Smooth-On Inc.) to avoid the calcium solution leaking 
from the inner region to the lumen extremities. The mineralization was then repeated 
alternatively between phosphate and calcium solutions for up to four weeks. 
 
A.5.8 Liquid flow test  
 
We measured the hydraulic flux through the hydrogel lumens using a custom built flow 
apparatus. The difference between input and output pressures (DP) displayed in two 
pressure gauges (McMaster Carr, 3847K71) along the lumens was measured while the 
flow rate (Q) was gradually increased at an interval of 25.2 mL min-1 (measured using 
an Omega, FLDA3422G; with measurement range of 0 to 325 mL min-1).[43] The neat 
and selectively mineralized hydrogel lumen was notated as NHL and MHL in the 
pressure curves, respectively. We analyzed the experimental data using ANOVA. The 
signiﬁcance level was set as p<0.05. Results were reported as mean ± standard 
deviation. 
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Figure A.1| SEM morphologies of polyacrylamide (PAAm) hydrogel loaded with 
phosphate ions. (a) before and (b-f) after repeated mineralization in calcium and 
phosphate solutions under different conditions: (b) 0.4 M solution for 1 week, (c) 0.4 M 
solution for 4 weeks, (d) 2 M solution for 1 week and (e) 2 M solution for 4 weeks, 
respectively. (f) Cross section of mineral gradient from edge to inner of a hydrogel 
sample after mineralized in 0.4 M solution for 1 week.  Insets are the sample images.  
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Figure A.2| FTIR spectra of polyacrylamide (PAAm) hydrogel loaded with 
phosphate ions. (a) before and (b-f) after repeated mineralization under different 
conditions. The symbols * and ∆ in (a) represent characteristic peaks associated with 
amide and PO34- groups of the polyacrylamide and minerals, respectively. NH and MH 
stand for neat hydrogel and mineralized hydrogel, respectively. 
 
 
Figure A.3| Mechanical properties tested via dynamic mechanical analysis (DMA) 
for PAAm hydrogels before and after repeated mineralization under different 
conditions. (a) Storage modulus along with frequency sweep and (b) Compressive 
stress−strain curves. NH, MH, HA (LC) and HA (CC) stand for neat hydrogel, 
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mineralized hydrogel, human aortic tissue (longitudinal cut) and human aortic tissue 
(circumferential cut), respectively.  
 
 
 
Figure A.4| Images of PAAm hydrogel lumen before and after repeated 
mineralization. (a) As-prepared PAAm hydrogel lumen with the inset cross section 
image. (b) Hydrogel lumen sitting in the 3D-printed mold for selective mineralization. 
(c) Hydrogel lumen after mineralization in 0.4 M solution for 4 weeks, compared with 
the original inner tube in the mold during curing and (d) Cross section view of the 
middle mineralized region (left) and non-mineralized region (right) within a same 
sample of (c).  
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Figure A.5| Water flow test across PAAm hydrogel lumens before and after 
repeated mineralization. (a) Scheme of hydraulic flow test setup. (b) Image of a 
selectively mineralized hydrogel lumen sample connected within the flow system. (c) 
Pressure difference across various hydrogel lumens with the increase of flow rate. NHL 
and MHL stand for neat hydrogel lumen and mineralized hydrogel lumen, respectively. 
Supplemental information is available in the online version of this paper.  
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HIGHLY STRETCHABLE ELECTROLUMINESCENT SKIN FOR OPTICAL 
SIGNALING AND TACTILE SENSING 
 
 
Chris M. Larson†, Bryan N. Peele†, Shuo Li†, Sanlin S. Robinson, Massimo Totaro, 
Lucia Beccai, Barbara Mazzolai, Robert F. Shepherd, Science, 2016, 351(6277), 1071 
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B.1 Abstract 
 
A hyperelastic light emitting capacitor, or HLEC, that can strain more than twice that 
of other stretchable displays is reported. This field-driven electroluminescent device is 
capable of stretching uniaxially to >480% strain and expanding its surface area by 
>635% while actively emitting light. These devices are layers of transparent hydrogel 
electrodes that sandwich a ZnS phosphor-doped dielectric elastomer layer, essentially 
thin rubber sheets that change illuminance and capacitance under deformation. An array 
of individually controllable HLEC pixels is fabricated using replica molding and 
subjected to stretching, folding, and rolling to demonstrate their use as stretchable 
displays. These sheets are then integrated into the skin of a soft robot, providing it with 
dynamic coloration and sensory feedback from external and internal stimuli. 
 
B.2 Introduction  
 
Biological systems employ a host of strategies for visual display and camouflage. 
Cephalopods, for example, can mimic their environment by changing skin color and 
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texture, as well as posture (1). Recent developments in soft robotics (2, 3), bioinspired 
design (4, 5), and stretchable electronics (6) reveal strategies that enable us to engineer 
some of the functions of cephalopod skin synthetically. For example, microfluidic 
networks filled with liquid dyes have been used as active camouflage and displays for 
soft mobile robots, giving them the ability to change their appearance via color, texture, 
and luminescence (7). More recently, electromechano-chemically responsive films were 
exploited to render fluorescent patterns under the control of electric fields (8), and 
adaptive optoelectronic camouflage systems have been used to mimic the visual 
appearance of cephalopod skin (9). Another approach is the use of active display 
technologies, such as polymeric light emitting devices (PLEDs) and organic light 
emitting diodes (OLEDs), which use stretchable, transparent electrodes based on indium 
tin oxide films (ITO) (10), graphene (11), single or multi-walled carbon nanotubes 
(SWNT, MWNTs) (12, 13), polyethylene-dioxythiophene: polystyrene-sulfonate 
(PEDOT:PSS) (14), or other percolated networks of conductive colloids or nanowires 
(15). Despite the broad applicability of LED-based systems for consumer displays, their 
electrical function is limited to ultimate strains, εult< 120% (16), well below the ultimate 
strain of elastomers (e.g. silicones; εult ~ 400 - 700%) that are used in soft robotics to 
mimic the movements of animals.  
 
Biological skin also enables animals to sense their environments. A number of 
approaches have been used to create pressure sensitive electronic skins, including arrays 
of organic field-effect transistors (FETs) deposited on flexible parylene-polyamide 
substrates (17, 18) and inside stretchable rubber (19), as well as thin Au films and liquid-
metal embedded in polydimethylsiloxane (PDMS) (20, 21). More recently, dielectric 
elastomer transducers (DETs), stretchable capacitors composed of highly extensible 
ionic hydrogels, have been used. These hydrogels are intrinsically soft, highly 
transparent in the visible spectrum (extinction coefficient, µext ~10-6 µm-1) (22), can 
exhibit very high ultimate strain (εult ~2,000%) and toughness (U ~9 kJ m-2) (23), and 
have relative changes in resistivity with strain that are orders of magnitude less than 
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electrodes based on percolated networks of conductive particles (e.g., metal 
nanoparticles, carbon powder, nanotubes) (24).  
 
Presently, soft robots are primarily used because their low mechanical compliance 
enables safe human robot interaction; however, their potential is limited by a lack of 
suitable electronics that can stretch continuously with their bodies. No soft robot can 
dynamically display information on its body, and there are relatively few examples that 
can sense external and internal stimuli. Here we present a hyperelastic light emitting 
capacitor, HLEC, that enables both light emission and touch sensing in a thin rubber 
sheet that stretches to >480% strain (Fig. B.1A).  
 
B.3 Design & Fabrication of HLECs  
 
These HLECs are comprised of ionic hydrogel electrodes and composites of doped ZnS 
phosphors embedded in a dielectric matrix of silicone elastomer. We use 
electroluminescent phosphor powders that emit light via excitations within intrinsic 
heterojunctions under an AC electric field; unlike current-driven LEDs which require 
lithography to form p-n junctions, this material system can be processed using replica 
molding. Application of an AC electric field causes luminescence within the 
semiconducting phosphor at wavelength centers corresponding to the dopants in the ZnS 
lattice. Green and blue centers are typically produced using low (~0.01 wt. %) and high 
(~0.1 wt. %) concentrations of Cu, while yellow is produced using Mn (~1 wt. %) (25). 
White light can be achieved using combinations of these dopants.  
 
The HLEC (Fig. B.1B) is a five-layer structure consisting of an electroluminescent 
dielectric layer that is sandwiched between two electrodes and encapsulated in low 
elastic modulus (E ~30 kPa) (26) silicone (Ecoflex 00-30, Smooth-on Inc.).  
 
Our hydrogel electrodes are designed with a balance of high mechanical toughness, low 
volatility, and low electrical resistance under deformation (Fig. SB.1). Aqueous lithium 
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chloride (LiCl) is used as the ionic conductor due to its high conductivity (~10 S m-1), 
ionic strength, and hygroscopic nature, while polyacrylamide (PAM) is used as the 
elastomeric matrix for its high toughness (27) and optical transparency. Electrodes are 
synthesized by first dissolving acrylamide monomer (AAm), polyacrylamide, and N,N’-
methylenebisacrylamide crosslinker in aqueous LiCl and casting the solution onto a 
UV-ozone treated silicone (Ecoflex 00-30) substrate. The aqueous PAM-AAm solution 
is then crosslinked under UV light (28), producing a highly stretchable and transparent 
electrode.  
 
The EL layer is formed by mixing commercially available phosphor powders (Global 
Tungsten & Powders Corp.) (25 µm, ~8 % by volume) into silicone (Ecoflex 00-30) and 
then molding the dispersion into to a 1 mm-thick sheet. Finally, we bond the EL layer 
between the two electrode patterned silicone substrates and encapsulate the capacitor in 
an insulating layer of silicone.  
 
B.4 HLEC Performance  
 
B.4.1 Mechanical  
 
The stress-strain curves of the HLEC and its silicone containing layers (Ecoflex and 
Ecoflex-EL composite) are all coincident, while the elastic modulus of the hydrogel is 
two orders of magnitude lower, allowing the HLEC to stretch freely without 
delaminating. Mechanical testing data (Fig. B.1C) and images (Fig. B.2A; Movie SB.1) 
show the excellent adhesion between the layers. The HLEC achieved a mean strain of 
487 ± 59% (SD), as measured at five locations across the width of the illuminated 
section, with portions exceeding 500% prior to the external copper leads losing contact 
with the hydrogel electrodes. For these tests, the HLECs were operated at 700 Hz under 
a nominal electric field of ~25 kV cm-1 with a power consumption of 0.2 W and a 
luminous efficacy of 43.2 millilumens per Watt (mlm W-1) (28). We use this same 
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replica molding technique to form an 8x8 array of 4 mm pixels (Fig. B.3A). This HLEC 
display can undergo many deformation modes including stretching, rolling, folding, and 
wrapping (Fig B.3B-E, Movie SB.2). Dynamic control of the pixels is shown in Figures 
B.3F-I.  
 
B.4.2 Dielectric elastomer sensor 
 
In addition to emitting light, the HLEC also serves as a dielectric elastomer sensor 
(DES) due to its construction as a parallel plate capacitor. Changes in the electrode area 
(A) and separation distance (d) cause the capacitance (C) to change according to 𝐶/𝐶0 
∝ 𝐴𝑑-1, allowing the HLEC to sense deformations from pressure and stretching. The 
capacitance of the HLEC changes as it is stretched under uniaxial (Fig. B.2B) and 
biaxial (Fig. SB.2) tension (28). We model the capacitance by expressing A and d in 
terms of the principal stretches, λ1, λ2, and λ3, which represent the axial, transverse, 
and out-of-plane orientations, respectively (supplementary text below). For uniaxial 
boundary conditions, we observe the relative capacitance increases linearly as the 
sample is stretched (Eq. SB.11). For biaxial test conditions, we observe that the relative 
change in capacitance follows 𝐶/𝐶0 = 𝜆4, (Eq. SB.12); however, at higher strains the 
measured values are slightly lower due to a decrease in the permittivity of the dielectric 
(24).  
 
B.4.3 Illuminance with stretching 
 
The illuminance of the HLEC also increases as the device is stretched. We attribute this 
change to two interrelated phenomena: i) the increase in electric field (E) as d decreases, 
and ii) the decrease in areal number density of phosphor particles (η) as A increases. 
Starting with the Alfrey-Taylor equation (Eq. SB.13, Fig. SB.3) (29), we predict the 
scaling law in Equation B.1 by expressing E/E0 as a function of the principal stretches 
and by correcting for the change in η with stretching (η/η0 ∝ A0/A) (supplementary text 
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below). The predicted trend is shown alongside luminescence measurements in Figure 
B.2C. 
 f = 	 𝜆R𝜆T QR𝑒𝑥𝑝 5.84 1 − 𝜆VR/T      (B.1) 
 
B.5 Crawling Robot 
 
To demonstrate our ability to monolithically integrate the HLEC into soft systems, we 
embedded three HLEC panels in a crawling soft robot by bonding six layers together. 
The top four layers comprise the electroluminescent skin, while the bottom two are used 
for pneumatic actuation (Fig. B.4A). Inspired by architectures developed for mobile soft 
robots (30), our pneumatic actuator uses a series of inflatable chambers embedded in 
silicone with a bottom layer comprised of inextensible fiber-elastomer composite (28). 
The inextensible layer induces a net bending moment as the pneumatic chambers are 
inflated; the resulting curvature is exploited to create an undulating gait. 
 
B.5.1 Proprioception & exteroception 
 
The crawling robot uses its HLEC skin to sense its physical state and environment (i.e. 
proprioception and exteroception). The capacitance of the HLEC changes with 
pneumatic actuation (Fig. B.4B) and externally applied pressure (Fig. B.4C, D). 
Actuation of the three underlying pneumatic chambers results in capacitance changes 
(ΔC) of up to 1,000% when the chambers are fully inflated. Additionally, each HLEC 
panel is largely decoupled from the state of the surrounding pneumatic chambers (Fig. 
SB.4) (28). The ability to identify the actuated state of the robot using the capacitive 
sensor readings enables proprioception.  
 
To demonstrate the tactile sensing capabilities of the electronic skin, we pressed each 
of the HLEC panels on the robot and measured the capacitive response (Fig B.4C). A 
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firm finger press resulted in a ~25% increase in capacitance. The relative capacitance 
versus applied pressure, ranging from 0.9 kPa to 30.9 kPa, remains nearly constant over 
a period of 120 hours (Fig. B.4D).  
 
Arrays of these tactile sensors enable exteroception in soft robotic systems. An array of 
three HLEC panels patterned into the three-chambered crawling robot enables eight 
distinct illuminated states (Fig. B.4E). The embedded HLEC remains functional as the 
robot is actuated through its crawling sequence (Fig. B.4F, Movie SB.3). During 
actuation, the embedded HLEC undergoes stretches of 𝜆1 = 2.63 and 𝜆2 = 2.42 in the 
longitudinal (front to rear) and transverse (side to side) directions, respectively, to 
produce a ~635% increase in the skin’s surface area (Fig. SB.5). Similar to the single-
panel HLEC (Movie S B.1), the luminescence of the embedded skin increases during 
actuation as its thickness is decreased.  
 
B.6 Conclusion 
 
Integrating these highly stretchable and compliant displays into soft actuators enables 
two new capabilities in soft electronics: (i) displays that actively change their shape and 
(ii) robots that actively change their color. Using replica molding we easily fabricated a 
multi-pixel array of individually addressable HLECs, and used the same process to 
monolithically integrate these displays into a soft robot capable of changing posture. 
The HLEC array imparts both dynamic coloration and the potential for feedback control, 
which would be useful in epidermal electronics (31) and robotics (32). While the 
luminous efficacy of our HLEC (43.2 mlm W-1) is not as high as commercial AC powder 
electroluminescent devices (~4 lm W-1) (32), it can be greatly improved by tuning the 
materials system and device architecture (e.g., higher transmissivity encapsulation 
layers, reduced thickness, optimized particle size). For applications requiring higher 
display resolution, HLECs could be made compatible with photolithography and other 
microfabrication techniques by using photo-polymerizable polymers. These techniques 
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would also allow us to decrease the thickness of the electroluminescent layer, thereby 
reducing the voltage required to power the HLEC. 
 
 
Figure B.1| Hyperelastic light emitting capacitor (HLEC). (A) Image of the HLEC 
conforming to the end of a pencil. (B) Exploded view of the HLEC showing its five-
layer structure consisting of a ~1 mm thick electroluminescent layer (ZnS-Ecoflex 00-
30) that is sandwiched between two PAM-LiCl hydrogel electrodes and encapsulated in 
Ecoflex 00-30. (C) Stress-stretch curves of Ecoflex 00-30, the electroluminescent layer, 
and the composite device. The hydrogel data is shown in the inset due to its much lower 
elastic modulus. 
 
 165 
 
Figure B.2| The capacitive and luminescent behavior of the HLEC display under 
uniaxial stretching. (A) A nominal electric field of ~25 kV cm-1 was applied to the 
HLEC at the start of the uniaxial test. Five lengths were measured using image analysis 
software to obtain 𝜆1 across the width of the illuminated portion of the tensile bar. We 
report the mean and standard deviation of those measurements. At an engineering strain 
(grip-to-grip) of 395%, we measured the mean strain of the illuminated portion to be 
487%, with a range of 420 - 549%. (B) The capacitance of the HLEC as a function of 
its uniaxial stretch (n = 4). (C) The relative illuminance of the HLEC versus its uniaxial 
stretch (n = 4) plotted alongside predicted values (supplementary text). 
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Figure B.3| Multi-pixel electroluminescent displays fabricated via replica molding. 
The device measures 5 mm thick, with each of the 64 pixels measuring 4 mm. We show 
the devices in various states of deformation and illumination: (A) undeformed, (B) 
stretched, (C) wrapped around a finger, (D) folded, (E) rolled, (F-H) subsets of pixels 
activated, and (I-J) subsets of pixels activated while being deformed. 
 
 
 
Figure B.4| HLEC skins endow soft robots with the ability to sense their actuated 
state, environment, and communicate optically. (A) Schematic of a three-chambered 
soft robot. A series of three independently actuated pneumatic chambers are embedded 
between the HLEC skin (top) and a strain limiting layer (bottom). (B) Capacitance 
plotted versus the actuation amplitude, defined as the relative change in deflection 
between the uninflated and fully inflated states (n = 5). (C) A firm finger press induces 
a ~25% increase in capacitance. (D) Change in capacitance versus applied pressure. We 
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observe a negligible change in the capacitive response of the sensors over a period of 
120 hours. (E) Array of three HLEC panels, each emitting a different wavelength 
through selective doping of the EL phosphor layer. Each HLEC panel is activated 
independently. (F) An undulating gait is produced by pressurizing the chambers in 
sequence along the length of the crawler. This sequence produces forward locomotion 
at a speed of ~4.8 m hr-1 (~32 body lengths hr-1). As each pneumatic chamber is 
pressurized, the outer electroluminescent skin is stretched, increasing the electric field 
across the EL layer and thus the luminescence. 
 
Supplemental Information is available in the online version of the paper. 
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